AngioDynamics Inc
Buy, Hold or Sell?

Let's analyse Angiodynamics together

Penke I guess you are interested in AngioDynamics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AngioDynamics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about AngioDynamics Inc

I send you an email if I find something interesting about AngioDynamics Inc.

Quick analysis of Angiodynamics (30 sec.)

What can you expect buying and holding a share of Angiodynamics? (30 sec.)

How much money do you get?

$0.00

When do you have the money?

1 year

How often do you get paid?

0.0%

What is your share worth?

Current worth

$5.37

Expected worth in 1 year

$0.76

How sure are you?

52.5%

+ What do you gain per year?

Total Gains per Share

$-4.61

Return On Investment

-75.3%

For what price can you sell your share?

Current Price per Share

$6.12

Expected price per share

$6.28 - $8.25

How sure are you?

50%

1. Valuation of Angiodynamics (5 min.)

Live pricePrice per Share (EOD)

$6.12

Book Value per Share

$5.37

Intrinsic Value Per Share

$-23.45 - $-1.82

Total Value Per Share

$-18.08 - $3.54

My calculation of the intrinsic value of Angiodynamics is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.08) 3Y: ($-0.10) TTM: ($-0.13)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($-0.01) 3Y: ($-0.04) TTM: ($-0.09)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$-0.73	$0.24	$-0.98 - $0.20
2	$-1.96	$0.36	$-1.57 - $0.09
3	$-3.62	$0.39	$-2.15 - $-0.01
4	$-5.66	$0.32	$-2.74 - $-0.12
5	$-8.03	$0.16	$-3.33 - $-0.22
6	$-10.69	$-0.09	$-3.91 - $-0.33
7	$-13.59	$-0.41	$-4.50 - $-0.44
8	$-16.71	$-0.81	$-5.08 - $-0.54
9	$-20.00	$-1.29	$-5.67 - $-0.65
10	$-23.45	$-1.82	$-6.25 - $-0.76

2. Growth of Angiodynamics (5 min.)

Is Angiodynamics growing?

	Current year	Previous year	Grow	Grow %
How rich?	$215.9m	$411m	-$55.2m	-15.5%

How much money is Angiodynamics making?

	Current year	Previous year	Grow	Grow %
Making money	-$48.7m	-$9.3m	-$39.4m	-80.9%
Net Profit Margin	-63.8%	-11.2%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Angiodynamics (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

Richest
#82 / 171

Most Revenue
#86 / 171

Most Profit
#165 / 171

Most Efficient
#141 / 171

What can you expect buying and holding a share of Angiodynamics? (5 min.)

Welcome investor! Angiodynamics's management wants to use your money to grow the business. In return you get a share of Angiodynamics.

What can you expect buying and holding a share of Angiodynamics?

First you should know what it really means to hold a share of Angiodynamics. And how you can make/lose money.

Speculation

The Price per Share of Angiodynamics is $6.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Angiodynamics.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Angiodynamics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.37. Based on the TTM, the Book Value Change Per Share is $-1.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.20 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Angiodynamics.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	-4.73	-77.3%	-0.79	-12.9%	-0.23	-3.8%	-0.40	-6.6%	-0.22	-3.6%
Usd Book Value Change Per Share	-4.61	-75.3%	-1.15	-18.8%	-0.20	-3.3%	-0.43	-7.0%	-0.20	-3.3%
Usd Dividend Per Share	0.00	0.0%	0.00	0.0%	0.00	0.0%	0.00	0.0%	0.00	0.0%
Usd Total Gains Per Share	-4.61	-75.3%	-1.15	-18.8%	-0.20	-3.3%	-0.43	-7.0%	-0.20	-3.3%
Usd Price Per Share	5.49	-	7.38	-	16.78	-	15.80	-	16.21	-
Price to Earnings Ratio	-0.29	-	0.31	-	-19.10	-	-26.82	-	-118.13	-
Price-to-Total Gains Ratio	-1.19	-	-5.75	-	-91.89	-	-234.88	-	164.56	-
Price to Book Ratio	1.02	-	0.86	-	1.62	-	1.40	-	1.32	-
Price-to-Total Gains Ratio	-1.19	-	-5.75	-	-91.89	-	-234.88	-	164.56	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	6.12
Number of shares	163

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.00	0.00
Usd Book Value Change Per Share	-1.15	-0.43
Usd Total Gains Per Share	-1.15	-0.43
Gains per Quarter (163 shares)	-187.82	-69.55
Gains per Year (163 shares)	-751.27	-278.20

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	0	-751	-761	0	-278	-288
2	0	-1503	-1512	0	-556	-566
3	0	-2254	-2263	0	-835	-844
4	0	-3005	-3014	0	-1113	-1122
5	0	-3756	-3765	0	-1391	-1400
6	0	-4508	-4516	0	-1669	-1678
7	0	-5259	-5267	0	-1947	-1956
8	0	-6010	-6018	0	-2226	-2234
9	0	-6761	-6769	0	-2504	-2512
10	0	-7513	-7520	0	-2782	-2790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	2.0	2.0	0.0	50.0%	2.0	10.0	0.0	16.7%	3.0	17.0	0.0	15.0%	14.0	26.0	0.0	35.0%	51.0	34.0	0.0	60.0%
Book Value Change Per Share	1.0	3.0	0.0	25.0%	1.0	11.0	0.0	8.3%	3.0	17.0	0.0	15.0%	21.0	19.0	0.0	52.5%	63.0	21.0	1.0	74.1%
Dividend per Share	0.0	0.0	4.0	0.0%	0.0	0.0	12.0	0.0%	0.0	0.0	20.0	0.0%	0.0	0.0	40.0	0.0%	0.0	0.0	85.0	0.0%
Total Gains per Share	1.0	3.0	0.0	25.0%	1.0	11.0	0.0	8.3%	3.0	17.0	0.0	15.0%	21.0	19.0	0.0	52.5%	63.0	21.0	1.0	74.1%

Fundamentals of Angiodynamics

About AngioDynamics Inc

https://www.angiodynamics.com
Medical Instruments & Supplies
815
14 Plaza Drive, Latham, NY, United States, 12110
Google Maps Bing Maps

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Fundamental data was last updated by Penke on 2024-04-11 00:38:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of AngioDynamics Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Angiodynamics earns for each $1 of revenue.

Above 10% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
A Net Profit Margin of -253.3% means that $-2.53 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AngioDynamics Inc:

The MRQ is -253.3%. The company is making a huge loss. -2
The TTM is -63.8%. The company is making a huge loss. -2

Trends

Current period		Compared to		+/-
MRQ	-253.3%	TTM	-63.8%	-189.5%
TTM	-63.8%	YOY	-11.2%	-52.6%
TTM	-63.8%	5Y	-29.5%	-34.4%
5Y	-29.5%	10Y	-15.3%	-14.2%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	-253.3%	6.3%	-259.6%
TTM	-63.8%	6.5%	-70.3%
YOY	-11.2%	8.2%	-19.4%
5Y	-29.5%	7.3%	-36.8%
10Y	-15.3%	7.6%	-22.9%

Measures how much net profit Angiodynamics earns for each $1 of revenue.

Revenue is the amount of profit Angiodynamics generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Angiodynamics earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be used to compare companies within the Medical Instruments & Supplies industry.

You typically want a high profit margin. This means that for each $1 in sales, Angiodynamics makes more profit. This shows the investor how efficiently Angiodynamics is operating in general and compared to other companies in the same industry. Angiodynamics operates in the Medical Instruments & Supplies industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Angiodynamics. If profit margins remain low (compared to the Medical Instruments & Supplies industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Angiodynamics is -2.53. This means that Angiodynamics earned $-2.53 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Instruments & Supplies industry is 6.3%.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Angiodynamics with other companies in the same industry (Medical Instruments & Supplies).
Net profit margin should rise over the years.
Can be influenced when Angiodynamics sells assets (profit will increase while costs remain the same).
It won’t show what part of Angiodynamics is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Angiodynamics

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Angiodynamics = -190,439
Total revenue MRQ Angiodynamics = 75,182
$-190,439 / $75,182 = -2.53 or -253.3%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Angiodynamics is using its assets to generate profit.

Above 5% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
-58.9% Return on Assets means that Angiodynamics generated $-0.59 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AngioDynamics Inc:

The MRQ is -58.9%. Using its assets, the company is very inefficient in making profit. -2
The TTM is -14.9%. Using its assets, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-58.9%	TTM	-14.9%	-44.0%
TTM	-14.9%	YOY	-1.7%	-13.2%
TTM	-14.9%	5Y	-4.8%	-10.1%
5Y	-4.8%	10Y	-2.5%	-2.3%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	-58.9%	1.3%	-60.2%
TTM	-14.9%	1.4%	-16.3%
YOY	-1.7%	2.0%	-3.7%
5Y	-4.8%	2.1%	-6.9%
10Y	-2.5%	2.0%	-4.5%

Shows how efficient Angiodynamics is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Angiodynamics is using its resources to generate profit. If the return on assets (-58.9%) from Angiodynamics are higher than the Medical Instruments & Supplies mean (1.3%) that means Angiodynamics is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Angiodynamics is -58.9%. This means the company generated $-0.59 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Instruments & Supplies industry is 1.3%.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Angiodynamics

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Angiodynamics = -190,439
Total assets MRQ (balance sheet) from Angiodynamics = 323,562
-190,439 / 323,562 = -0.59 or -58.9%

ROA is an important ratio as it will tell you how effectively Angiodynamics is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Angiodynamics is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
-88.2% Return on Equity means Angiodynamics generated $-0.88 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AngioDynamics Inc:

The MRQ is -88.2%. Using its investors money, the company is very inefficient in making profit. -2
The TTM is -22.6%. Using its investors money, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-88.2%	TTM	-22.6%	-65.6%
TTM	-22.6%	YOY	-2.3%	-20.3%
TTM	-22.6%	5Y	-6.9%	-15.7%
5Y	-6.9%	10Y	-3.6%	-3.3%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	-88.2%	2.6%	-90.8%
TTM	-22.6%	2.9%	-25.5%
YOY	-2.3%	3.9%	-6.2%
5Y	-6.9%	3.8%	-10.7%
10Y	-3.6%	3.9%	-7.5%

Shows how efficient Angiodynamics is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Instruments & Supplies industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Angiodynamics is -88.2%. This means Angiodynamics generated $-0.88 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Instruments & Supplies industry is 2.6%.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if Angiodynamics existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Angiodynamics

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Angiodynamics = -190,439
Shareholders equity (balance sheet) MRQ Angiodynamics = 215,995
-190,439 / 215,995 = -0.88 or -88.2%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of AngioDynamics Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Angiodynamics is operating .

Measures how much profit Angiodynamics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
An Operating Margin of -15.4% means the company generated $-0.15 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AngioDynamics Inc:

The MRQ is -15.4%. The company is operating very inefficient. -2
The TTM is -22.0%. The company is operating very inefficient. -2

Trends

Current period		Compared to		+/-
MRQ	-15.4%	TTM	-22.0%	+6.5%
TTM	-22.0%	YOY	-6.3%	-15.7%
TTM	-22.0%	5Y	-5.9%	-16.1%
5Y	-5.9%	10Y	1.4%	-7.3%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	-15.4%	7.9%	-23.3%
TTM	-22.0%	7.5%	-29.5%
YOY	-6.3%	11.4%	-17.7%
5Y	-5.9%	10.2%	-16.1%
10Y	1.4%	10.7%	-9.3%

Measures how efficient Angiodynamics is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Angiodynamics is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Angiodynamics is -15.4%. This means that Angiodynamics earned $-0.15 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Instruments & Supplies industry is 7.9%.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Angiodynamics

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Angiodynamics = -11,598
Total revenue MRQ Angiodynamics = 75,182
$-11,598 / $75,182 = -0.15 or -15.4%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Angiodynamics is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
An Operation Ratio of 1.15 means that the operating costs are $1.15 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AngioDynamics Inc:

The MRQ is 1.154. The company is inefficient in keeping operating costs low. -1
The TTM is 1.097. The company is inefficient in keeping operating costs low. -1

Trends

Current period		Compared to		+/-
MRQ	1.154	TTM	1.097	+0.057
TTM	1.097	YOY	1.062	+0.036
TTM	1.097	5Y	1.058	+0.040
5Y	1.058	10Y	0.997	+0.060

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	1.154	1.133	+0.021
TTM	1.097	1.124	-0.027
YOY	1.062	1.105	-0.043
5Y	1.058	1.097	-0.039
10Y	0.997	1.056	-0.059

Measures how efficient Angiodynamics is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Angiodynamics is 115.4%. This means that Angiodynamics earned $1.15 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Instruments & Supplies industry is 1.13.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Angiodynamics

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(42,608 +44,172) \ 75,182 = 1.15

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of AngioDynamics Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Angiodynamics is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A Current Ratio of 2.29 means the company has $2.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AngioDynamics Inc:

The MRQ is 2.293. The company is able to pay all its short-term debts. +1
The TTM is 2.419. The company is able to pay all its short-term debts. +1

Trends

Current period		Compared to		+/-
MRQ	2.293	TTM	2.419	-0.126
TTM	2.419	YOY	2.140	+0.279
TTM	2.419	5Y	2.685	-0.267
5Y	2.685	10Y	2.630	+0.055

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	2.293	2.320	-0.027
TTM	2.419	2.382	+0.037
YOY	2.140	2.575	-0.435
5Y	2.685	2.627	+0.058
10Y	2.630	2.623	+0.007

Measures if Angiodynamics is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Angiodynamics if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Angiodynamics is 2.29. This means Angiodynamics has $2.29 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 2.32.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Angiodynamics

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
196,907 \ 85,874) = 2.29

The current ratio measures if Angiodynamics is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Angiodynamics is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Angiodynamics does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Angiodynamics is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Angiodynamics is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
A Quick Ratio of 1.49 means the company can pay off $1.49 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AngioDynamics Inc:

The MRQ is 1.490. The company is able to pay all its short-term debts with the most liquid assets. +1
The TTM is 1.491. The company is able to pay all its short-term debts with the most liquid assets. +1

Trends

Current period		Compared to		+/-
MRQ	1.490	TTM	1.491	-0.001
TTM	1.491	YOY	1.139	+0.351
TTM	1.491	5Y	1.611	-0.120
5Y	1.611	10Y	1.536	+0.075

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	1.490	1.111	+0.379
TTM	1.491	1.159	+0.332
YOY	1.139	1.286	-0.147
5Y	1.611	1.423	+0.188
10Y	1.536	1.521	+0.015

Measures if Angiodynamics is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Angiodynamics can pay off its short term debts. This shows if Angiodynamics can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Angiodynamics is 1.49. This means that Angiodynamics can pay off $1.49 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 1.11.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Angiodynamics

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Angiodynamics: (78,451 + 0 +49,475) / 85,874 = 1.49

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of AngioDynamics Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Angiodynamics assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Angiodynamics to Medical Instruments & Supplies industry mean.
A Debt to Asset Ratio of 0.33 means that Angiodynamics assets are financed with 33.2% credit (debt) and the remaining percentage (100% - 33.2%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of AngioDynamics Inc:

The MRQ is 0.332. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.238. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.332	TTM	0.238	+0.094
TTM	0.238	YOY	0.257	-0.018
TTM	0.238	5Y	0.222	+0.016
5Y	0.222	10Y	0.250	-0.028

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.332	0.351	-0.019
TTM	0.238	0.357	-0.119
YOY	0.257	0.357	-0.100
5Y	0.222	0.359	-0.137
10Y	0.250	0.371	-0.121

Measures how much % of Angiodynamics assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Angiodynamics than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Angiodynamics to Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Angiodynamics is 0.33. This means means that Angiodynamics is financed with 33.2% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 232.0%.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Angiodynamics has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Angiodynamics

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
107,567 \ 323,562 = 33.2% or 0.33.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Angiodynamics is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
A Debt to Equity ratio of 49.8% means that company has $0.50 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AngioDynamics Inc:

The MRQ is 0.498. The company is very able to pay all its debts with equity. +2
The TTM is 0.326. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.498	TTM	0.326	+0.172
TTM	0.326	YOY	0.346	-0.019
TTM	0.326	5Y	0.291	+0.036
5Y	0.291	10Y	0.339	-0.049

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.498	0.541	-0.043
TTM	0.326	0.559	-0.233
YOY	0.346	0.545	-0.199
5Y	0.291	0.610	-0.319
10Y	0.339	0.669	-0.330

Measures if Angiodynamics is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Angiodynamics is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Angiodynamics is 0.50. This means that Angiodynamics can pay off $0.50 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 0.54.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Angiodynamics

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
107,567 \ 215,995 = 0.50 or 49.8%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of AngioDynamics Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Angiodynamics generates.

Above 15 is considered overpriced but always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
A PE ratio of -0.29 means the investor is paying $-0.29 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AngioDynamics Inc:

The EOD is -0.323. Based on the earnings, the company is expensive. -2
The MRQ is -0.290. Based on the earnings, the company is expensive. -2
The TTM is 0.313. Based on the earnings, the company is cheap. +2

Trends

Current period		Compared to		+/-
EOD	-0.323	MRQ	-0.290	-0.033
MRQ	-0.290	TTM	0.313	-0.603
TTM	0.313	YOY	-19.097	+19.410
TTM	0.313	5Y	-26.822	+27.135
5Y	-26.822	10Y	-118.133	+91.311

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	-0.323	15.252	-15.575
MRQ	-0.290	17.745	-18.035
TTM	0.313	18.883	-18.570
YOY	-19.097	22.890	-41.987
5Y	-26.822	21.018	-47.840
10Y	-118.133	26.090	-144.223

Measures how much money you pay for each share for every $1 in earnings Angiodynamics generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Angiodynamics to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Angiodynamics is -0.29. This means the investor is paying $-0.29 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 17.75.
What is the trend?
The trend is important because it shows you how Angiodynamics is performing over time. The most recent quarter might be important if Angiodynamics released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Angiodynamics up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Angiodynamics

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 40,234 = EPS
PE ratio MRQ = -0.29

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AngioDynamics Inc:

The EOD is -4.687. Based on how much money comes from the company's main activities, the company is expensive. -2
The MRQ is -4.205. Based on how much money comes from the company's main activities, the company is expensive. -2
The TTM is 3.262. Based on how much money comes from the company's main activities, the company is cheap. +2

Trends

Current period		Compared to		+/-
EOD	-4.687	MRQ	-4.205	-0.483
MRQ	-4.205	TTM	3.262	-7.467
TTM	3.262	YOY	53.380	-50.117
TTM	3.262	5Y	34.254	-30.991
5Y	34.254	10Y	39.428	-5.175

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	-4.687	10.158	-14.845
MRQ	-4.205	10.068	-14.273
TTM	3.262	1.502	+1.760
YOY	53.380	4.281	+49.099
5Y	34.254	7.622	+26.632
10Y	39.428	0.247	+39.181

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Angiodynamics is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A PB ratio of 1.02 means the investor is paying $1.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AngioDynamics Inc:

The EOD is 1.140. Based on the equity, the company is underpriced. +1
The MRQ is 1.023. Based on the equity, the company is underpriced. +1
The TTM is 0.856. Based on the equity, the company is cheap. +2

Trends

Current period		Compared to		+/-
EOD	1.140	MRQ	1.023	+0.117
MRQ	1.023	TTM	0.856	+0.167
TTM	0.856	YOY	1.620	-0.764
TTM	0.856	5Y	1.405	-0.549
5Y	1.405	10Y	1.320	+0.085

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	1.140	2.434	-1.294
MRQ	1.023	2.782	-1.759
TTM	0.856	2.767	-1.911
YOY	1.620	3.290	-1.670
5Y	1.405	3.530	-2.125
10Y	1.320	4.227	-2.907

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AngioDynamics Inc.

3.1. Institutions holding AngioDynamics Inc

Institutions are holding 91.762% of the shares of AngioDynamics Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	BlackRock Inc	12.6561	0.001	5044098	882214	21.1975
2023-12-31	Vanguard Group Inc	5.6918	0.0004	2268461	136323	6.3937
2023-12-31	Systematic Financial Management LP	4.8479	0.4494	1932154	31374	1.6506
2023-12-31	Morgan Stanley - Brokerage Accounts	4.7326	0.0013	1886200	335210	21.6126
2023-12-31	Millennium Management LLC	4.6061	0.0062	1835777	-861894	-31.9496
2023-12-31	Dimensional Fund Advisors, Inc.	3.7363	0.0034	1489108	-181635	-10.8715
2023-12-31	Assenagon Asset Management SA	2.6446	0.0219	1054022	0	0
2023-09-30	Citadel Advisors Llc	2.5347	0.0016	1010197	470975	87.3434
2023-12-31	State Street Corporation	2.5324	0.0004	1009307	-256028	-20.234
2023-12-31	Acadian Asset Management LLC	2.2693	0.0275	904422	544381	151.1997
2023-12-31	Geode Capital Management, LLC	2.2502	0.0007	896808	49508	5.843
2023-12-31	Renaissance Technologies Corp	2.1681	0.0105	864083	205769	31.257
2023-12-31	Armistice Capital, LLC	2.0073	0.0856	800000	800000	0
2023-09-30	Jacobs Levy Equity Management, Inc.	1.7912	0.0309	713899	274210	62.3645
2023-12-31	JPMorgan Chase & Co	1.7702	0.0005	705522	113707	19.2133
2023-12-31	AQR Capital Management LLC	1.7419	0.0102	694226	471070	211.0945
2023-12-31	Two Sigma Advisers, LLC	1.7315	0.0127	690100	-90300	-11.571
2023-09-30	D. E. Shaw & Co LP	1.7212	0.0052	685999	291210	73.7635
2023-12-31	Two Sigma Investments LLC	1.6442	0.0118	655313	-51562	-7.2944
2023-12-31	ExodusPoint Capital Management, LP	1.5797	0.0324	629603	-187789	-22.9742
Total		64.6573	0.7136	25769299	+2976743	+11.6%

3.2. Funds holding AngioDynamics Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	Vanguard Total Stock Mkt Idx Inv	3.0426	0.0004	1212644	0	0
2024-03-28	iShares Russell 2000 ETF	2.3527	0.0084	937686	453	0.0483
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.5854	0.0034	631882	0	0
2023-12-31	Acuitas US Microcap Strategy	1.0119	0.842	403280	31480	8.4669
2024-01-31	Fidelity Small Cap Index	0.9784	0.0093	389950	0	0
2024-03-28	iShares Russell 2000 Value ETF	0.8893	0.0166	354421	-225	-0.0634
2024-02-29	DFA US Small Cap Value I	0.8681	0.0124	345996	-17050	-4.6964
2024-03-31	Paradigm Micro-Cap	0.7527	1.0673	300000	0	0
2024-01-31	TIAA-CREF Quant Small-Cap Equity Instl	0.6438	0.0505	256570	0	0
2024-02-29	Fidelity Extended Market Index	0.6056	0.0035	241370	18566	8.3329
2024-02-29	State St Russell Sm/Mid Cp® Indx NL Cl C	0.5976	0.0031	238172	7200	3.1173
2024-02-29	BlackRock Advantage Small Cap Core Instl	0.5863	0.0366	233676	-14899	-5.9938
2024-03-28	SPDR® S&P Kensho New Economies Comps ETF	0.569	0.0666	226775	0	0
2024-03-29	Schwab US Small-Cap ETF™	0.4872	0.0067	194194	0	0
2024-02-29	DFA US Targeted Value I	0.4566	0.0077	181974	0	0
2024-02-29	Transamerica Small/Mid Cap Value A	0.3849	0.1188	153400	0	0
2024-02-29	Vanguard Russell 2000 ETF	0.3528	0.0081	140612	11036	8.517
2024-02-29	JPMorgan US Small Company L	0.3422	0.0763	136395	0	0
2024-03-31	State St Russell Sm Cap® Indx SL Cl I	0.3416	0.0082	136128	0	0
2023-08-17	MUAM Nanotechnology Related Eq Idx MF	0.3406	5.7427	135737	53345	64.7454
Total		17.1893	8.0886	6850862	+89906	+1.3%

3.3. Insider Transactions

Insiders are holding 4.997% of the shares of AngioDynamics Inc.

Date	Owner	Type	Amount	Price	Post Transaction Amount	Link
2024-04-08	James C Clemmer	BUY	10000	6.7

4. Summary

4.1. Key Performance Indicators

The key performance indicators of AngioDynamics Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	-4.608	-1.152	-75%	-0.201	-96%	-0.427	-91%	-0.203	-96%
Book Value Per Share	-	-	5.368	8.885	-40%	10.313	-48%	11.380	-53%	12.412	-57%
Current Ratio	-	-	2.293	2.419	-5%	2.140	+7%	2.685	-15%	2.630	-13%
Debt To Asset Ratio	-	-	0.332	0.238	+40%	0.257	+30%	0.222	+50%	0.250	+33%
Debt To Equity Ratio	-	-	0.498	0.326	+53%	0.346	+44%	0.291	+71%	0.339	+47%
Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Eps	-	-	-4.733	-0.789	-83%	-0.234	-95%	-0.405	-91%	-0.219	-95%
Free Cash Flow Per Share	-	-	-0.326	-0.126	-61%	-0.073	-78%	-0.048	-85%	0.077	-526%
Free Cash Flow To Equity Per Share	-	-	-0.309	-1.626	+426%	0.088	-450%	-0.456	+48%	-0.152	-51%
Gross Profit Margin	-	-	1.133	1.410	-20%	4.017	-72%	4.288	-74%	15.323	-93%
Intrinsic Value_10Y_max	-	-	-1.824	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-23.446	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	0.236	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	-0.735	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	0.391	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-3.619	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	0.160	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-8.029	-	-	-	-	-	-	-	-
Market Cap	243913824.000	+9%	220884660.000	295371990.500	-25%	668570980.000	-67%	630129667.500	-65%	646112088.750	-66%
Net Profit Margin	-	-	-2.533	-0.638	-75%	-0.112	-96%	-0.295	-88%	-0.153	-94%
Operating Margin	-	-	-0.154	-0.220	+42%	-0.063	-59%	-0.059	-62%	0.014	-1203%
Operating Ratio	-	-	1.154	1.097	+5%	1.062	+9%	1.058	+9%	0.997	+16%
Pb Ratio	1.140	+10%	1.023	0.856	+19%	1.620	-37%	1.405	-27%	1.320	-23%
Pe Ratio	-0.323	-11%	-0.290	0.313	-193%	-19.097	+6486%	-26.822	+9150%	-118.133	+40640%
Price Per Share	6.120	+10%	5.490	7.378	-26%	16.775	-67%	15.804	-65%	16.208	-66%
Price To Free Cash Flow Ratio	-4.687	-11%	-4.205	3.262	-229%	53.380	-108%	34.254	-112%	39.428	-111%
Price To Total Gains Ratio	-1.328	-11%	-1.192	-5.754	+383%	-91.890	+7612%	-234.877	+19612%	164.564	-101%
Quick Ratio	-	-	1.490	1.491	0%	1.139	+31%	1.611	-8%	1.536	-3%
Return On Assets	-	-	-0.589	-0.149	-75%	-0.017	-97%	-0.048	-92%	-0.025	-96%
Return On Equity	-	-	-0.882	-0.226	-74%	-0.023	-97%	-0.069	-92%	-0.036	-96%
Total Gains Per Share	-	-	-4.608	-1.152	-75%	-0.201	-96%	-0.427	-91%	-0.203	-96%
Usd Book Value	-	-	215995000.000	355830250.000	-39%	411035750.000	-47%	453915450.000	-52%	494870275.000	-56%
Usd Book Value Change Per Share	-	-	-4.608	-1.152	-75%	-0.201	-96%	-0.427	-91%	-0.203	-96%
Usd Book Value Per Share	-	-	5.368	8.885	-40%	10.313	-48%	11.380	-53%	12.412	-57%
Usd Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Usd Eps	-	-	-4.733	-0.789	-83%	-0.234	-95%	-0.405	-91%	-0.219	-95%
Usd Free Cash Flow	-	-	-13133000.000	-5053250.000	-62%	-2912750.000	-78%	-1921800.000	-85%	3053250.000	-530%
Usd Free Cash Flow Per Share	-	-	-0.326	-0.126	-61%	-0.073	-78%	-0.048	-85%	0.077	-526%
Usd Free Cash Flow To Equity Per Share	-	-	-0.309	-1.626	+426%	0.088	-450%	-0.456	+48%	-0.152	-51%
Usd Market Cap	243913824.000	+9%	220884660.000	295371990.500	-25%	668570980.000	-67%	630129667.500	-65%	646112088.750	-66%
Usd Price Per Share	6.120	+10%	5.490	7.378	-26%	16.775	-67%	15.804	-65%	16.208	-66%
Usd Profit	-	-	-190439000.000	-48767500.000	-74%	-9310250.000	-95%	-19552700.000	-90%	-10347050.000	-95%
Usd Revenue	-	-	75182000.000	81002000.000	-7%	83669000.000	-10%	76968600.000	-2%	82530325.000	-9%
Usd Total Gains Per Share	-	-	-4.608	-1.152	-75%	-0.201	-96%	-0.427	-91%	-0.203	-96%
	EOD	+5 -3	MRQ	TTM	+7 -27	YOY	+6 -28	5Y	+6 -28	10Y	+3 -31

4.2. Fundamental Score

Let's check the fundamental score of AngioDynamics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	-0.323
Price to Book Ratio (EOD)	Between	0-1	1.140
Net Profit Margin (MRQ)	Greater than	0	-2.533
Operating Margin (MRQ)	Greater than	0	-0.154
Quick Ratio (MRQ)	Greater than	1	1.490
Current Ratio (MRQ)	Greater than	1	2.293
Debt to Asset Ratio (MRQ)	Less than	1	0.332
Debt to Equity Ratio (MRQ)	Less than	1	0.498
Return on Equity (MRQ)	Greater than	0.15	-0.882
Return on Assets (MRQ)	Greater than	0.05	-0.589
Total			4/10 (40.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of AngioDynamics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	48.983
Ma 20	Greater than	Ma 50	6.176
Ma 50	Greater than	Ma 100	5.935
Ma 100	Greater than	Ma 200	6.340
Open	Greater than	Close	6.350
Total			2/5 (40.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2024-02-29. Currency in USD. All numbers in thousands.

Summary

Total Assets	323,562
Total Liabilities	107,567
Total Stockholder Equity	215,995

	As reported
Total Liabilities	107,567
Total Stockholder Equity	+ 215,995
Total Assets	= 323,562

Assets

Total Assets	323,562
Total Current Assets	196,907
Long-term Assets	126,655

Total Current Assets

Total Current Assets (as reported)	196,907
Cash And Cash Equivalents	78,451
Net Receivables	49,475
Inventory	58,068
Other Current Assets	10,913
Total Current Assets (calculated)	196,907
+/-	0

Long-term Assets

Long-term Assets (as reported)	126,655
Property Plant Equipment	37,040
Intangible Assets	81,570
Long-term Assets Other	8,045
Long-term Assets (calculated)	126,655
+/-	0

Liabilities & Shareholders' Equity

Total Current Liabilities	85,874
Long-term Liabilities	21,693
Total Stockholder Equity	215,995

Total Current Liabilities

Total Current Liabilities (as reported)	85,874
Accounts payable	35,152
Other Current Liabilities	50,722
Total Current Liabilities (calculated)	85,874
+/-	0

Long-term Liabilities

Long-term Liabilities (as reported)	21,693
Long-term Liabilities (calculated)	0
+/-	21,693

Total Stockholder Equity

Total Stockholder Equity (as reported)	215,995
Other Stockholders Equity	215,995
Total Stockholder Equity (calculated)	215,995
+/-	0

Other

Cash and Short Term Investments	78,451
Common Stock Shares Outstanding	40,234
Liabilities and Stockholders Equity	323,562
Net Debt	-78,451
Net Working Capital	111,033

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2024-02-29

2023-11-30

2023-08-31

2023-05-31

2023-02-28

2022-11-30

2022-08-31

2022-05-31

2022-02-28

2021-11-30

2021-08-31

2021-05-31

2021-02-28

2020-11-30

2020-08-31

2020-05-31

2020-02-29

2019-11-30

2019-08-31

2019-05-31

2019-02-28

2018-11-30

2018-08-31

2018-05-31

2018-02-28

2017-11-30

2017-08-31

2017-05-31

2017-02-28

2016-11-30

2016-08-31

2016-05-31

2016-02-29

2015-11-30

2015-08-31

2015-05-31

2015-02-28

2014-11-30

2014-08-31

2014-05-31

2014-02-28

2013-11-30

2013-08-31

2013-05-31

2013-02-28

2012-11-30

2012-08-31

2012-05-31

2012-02-29

2011-11-30

2011-08-31

2011-05-31

2011-02-28

2010-11-30

2010-08-31

2010-05-31

2010-02-28

2009-11-30

2009-08-31

2009-05-31

2009-02-28

2008-11-30

2008-08-31

2008-05-31

2008-02-29

2007-11-30

2007-08-31

2007-05-31

2007-02-28

2006-11-30

2006-08-31

2006-05-31

2006-02-28

2005-11-30

2005-08-31

2005-05-31

2005-02-28

2004-11-30

2004-08-31

2004-05-31

2004-02-29

2003-11-30

2003-05-31

2003-02-28

2002-05-31

> Total Assets

20,647
0
27,056
28,542
29,072
49,726
48,630
50,372
53,835
59,672
61,335
64,238
70,227
137,000
141,758
149,114
377,280
383,281
385,040
392,820
396,939
408,747
395,970
392,951
400,579
408,703
409,280
407,633
412,295
423,925
420,351
425,983
433,399
437,546
439,608
443,590
446,607
725,077
717,992
778,947
796,471
791,882
801,153
795,490
792,174
800,157
797,295
799,330
783,136
773,623
771,789
760,371
753,513
728,063
726,711
712,170
704,318
707,961
700,341
697,806
698,429
705,472
693,871
783,960
777,795
836,438
690,364
724,879
731,961
595,512
583,759
588,521
582,245
561,438
555,763
554,103
543,178
552,751
557,652
558,207
542,849
532,637
493,949
499,623
323,562

323,562

499,623

493,949

532,637

542,849

558,207

557,652

552,751

543,178

554,103

555,763

561,438

582,245

588,521

583,759

595,512

731,961

724,879

690,364

836,438

777,795

783,960

693,871

705,472

698,429

697,806

700,341

707,961

704,318

712,170

726,711

728,063

753,513

760,371

771,789

773,623

783,136

799,330

797,295

800,157

792,174

795,490

801,153

791,882

796,471

778,947

717,992

725,077

446,607

443,590

439,608

437,546

433,399

425,983

420,351

423,925

412,295

407,633

409,280

408,703

400,579

392,951

395,970

408,747

396,939

392,820

385,040

383,281

377,280

149,114

141,758

137,000

70,227

64,238

61,335

59,672

53,835

50,372

48,630

49,726

29,072

28,542

27,056

20,647

> Total Current Assets

0
0
18,525
0
19,736
40,375
39,203
40,871
44,452
49,707
51,036
50,748
56,097
122,156
121,998
123,716
121,219
127,861
126,659
134,428
140,625
141,882
125,435
124,123
134,617
148,598
152,684
151,627
158,351
171,360
169,782
177,446
186,567
194,430
199,866
205,836
211,049
159,278
160,221
151,463
146,440
141,573
145,234
141,573
140,131
152,236
154,802
163,446
157,292
155,813
160,025
151,558
149,401
146,254
152,282
147,802
145,051
153,914
150,722
152,495
156,569
168,032
120,885
142,957
142,740
315,292
166,357
131,976
129,046
152,913
142,238
149,704
145,657
140,879
131,321
132,185
127,686
143,345
151,371
158,830
152,574
163,542
175,475
185,468
196,907

196,907

185,468

175,475

163,542

152,574

158,830

151,371

143,345

127,686

132,185

131,321

140,879

145,657

149,704

142,238

152,913

129,046

131,976

166,357

315,292

142,740

142,957

120,885

168,032

156,569

152,495

150,722

153,914

145,051

147,802

152,282

146,254

149,401

151,558

160,025

155,813

157,292

163,446

154,802

152,236

140,131

141,573

145,234

141,573

146,440

151,463

160,221

159,278

211,049

205,836

199,866

194,430

186,567

177,446

169,782

171,360

158,351

151,627

152,684

148,598

134,617

124,123

125,435

141,882

140,625

134,428

126,659

127,861

121,219

123,716

121,998

122,156

56,097

50,748

51,036

49,707

44,452

40,871

39,203

40,375

19,736

18,525

Cash And Cash Equivalents

1,525
0
939
0
1,332
1,747
20,749
11,849
15,404
14,498
13,298
13,043
13,356
64,042
70,786
73,158
38,052
28,313
23,426
22,759
43,646
32,040
18,518
19,734
26,776
27,909
32,168
36,256
37,513
58,763
67,202
27,132
35,257
45,984
50,493
42,955
34,047
23,508
18,896
19,322
16,625
21,802
22,065
15,173
7,382
16,105
13,808
14,877
19,704
18,391
20,268
18,996
21,897
32,333
37,411
35,664
35,571
47,544
48,200
49,856
52,292
74,096
24,762
42,820
41,704
227,641
83,649
41,247
27,160
54,435
47,929
58,025
54,469
48,161
35,472
34,291
23,890
28,825
24,564
29,857
30,111
44,620
57,586
60,896
78,451

78,451

60,896

57,586

44,620

30,111

29,857

24,564

28,825

23,890

34,291

35,472

48,161

54,469

58,025

47,929

54,435

27,160

41,247

83,649

227,641

41,704

42,820

24,762

74,096

52,292

49,856

48,200

47,544

35,571

35,664

37,411

32,333

21,897

18,996

20,268

18,391

19,704

14,877

13,808

16,105

7,382

15,173

22,065

21,802

16,625

19,322

18,896

23,508

34,047

42,955

50,493

45,984

35,257

27,132

67,202

58,763

37,513

36,256

32,168

27,909

26,776

19,734

18,518

32,040

43,646

22,759

23,426

28,313

38,052

73,158

70,786

64,042

13,356

13,043

13,298

14,498

15,404

11,849

20,749

1,747

1,332

939

1,525

Short-term Investments

1,318
0
729
0
735
737
739
10,354
9,590
12,601
15,516
14,440
15,551
25,710
18,421
14,790
28,977
43,191
46,167
45,612
34,206
46,182
40,731
38,108
35,557
40,278
36,588
37,772
48,265
41,311
34,796
83,471
84,973
85,558
86,158
93,364
108,980
14,070
11,627
2,155
2,154
2,153
1,850
1,850
1,807
1,809
1,670
1,698
1,682
1,689
1,692
1,639
1,666
1,653
1,647
1,203
1,203
1,215
1,215
1,260
1,281
1,317
1,350
1,350
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,350

1,317

1,281

1,260

1,215

1,203

1,647

1,653

1,666

1,639

1,692

1,689

1,682

1,698

1,670

1,809

1,807

1,850

2,153

2,154

2,155

11,627

14,070

108,980

93,364

86,158

85,558

84,973

83,471

34,796

41,311

48,265

37,772

36,588

40,278

35,557

38,108

40,731

46,182

34,206

45,612

46,167

43,191

28,977

14,790

18,421

25,710

15,551

14,440

15,516

12,601

9,590

10,354

739

737

735

729

1,318

Net Receivables

0
0
6,532
0
7,332
27,894
7,176
7,936
8,350
9,929
9,484
10,814
12,182
13,486
12,135
14,213
18,929
20,798
19,686
22,216
22,762
26,642
24,375
25,733
26,501
27,181
23,383
25,397
26,536
29,838
23,637
25,762
28,461
27,365
26,365
31,451
26,723
51,088
47,928
49,585
45,110
48,090
46,561
48,405
57,726
62,155
56,257
58,556
57,770
58,428
52,424
53,118
54,446
52,867
50,124
50,171
46,302
44,523
41,283
42,073
41,827
39,401
40,164
43,374
44,208
43,577
32,540
33,994
35,619
31,263
33,590
33,604
33,171
35,405
35,416
38,205
41,810
52,304
53,586
52,852
50,892
52,826
49,755
51,603
49,475

49,475

51,603

49,755

52,826

50,892

52,852

53,586

52,304

41,810

38,205

35,416

35,405

33,171

33,604

33,590

31,263

35,619

33,994

32,540

43,577

44,208

43,374

40,164

39,401

41,827

42,073

41,283

44,523

46,302

50,171

50,124

52,867

54,446

53,118

52,424

58,428

57,770

58,556

56,257

62,155

57,726

48,405

46,561

48,090

45,110

49,585

47,928

51,088

26,723

31,451

26,365

27,365

28,461

25,762

23,637

29,838

26,536

25,397

23,383

27,181

26,501

25,733

24,375

26,642

22,762

22,216

19,686

20,798

18,929

14,213

12,135

13,486

12,182

10,814

9,484

9,929

8,350

7,936

7,176

27,894

7,332

6,532

Other Current Assets

665
0
1,694
955
1,351
1,452
1,323
1,687
1,720
1,679
1,740
1,746
1,871
2,950
2,235
2,868
7,933
6,990
6,626
1
14,687
14,117
13,612
11,964
13,368
16,302
16,201
12,328
11,922
12,232
10,630
8,350
8,387
7,496
7,178
8,639
13,141
14,749
6,507
18,071
20,578
994
15,509
16,093
13,382
11,110
12,380
13,000
9,426
9,917
11,314
6,992
5,600
2,098
4,826
4,097
4,294
2,762
4,599
5,274
4,605
2,505
4,888
4,776
4,440
2,203
4,939
6,496
11,369
2,238
7,957
8,493
9,011
1,760
11,128
11,506
13,947
2,201
15,612
12,944
8,039
4,617
8,162
8,715
10,913

10,913

8,715

8,162

4,617

8,039

12,944

15,612

2,201

13,947

11,506

11,128

1,760

9,011

8,493

7,957

2,238

11,369

6,496

4,939

2,203

4,440

4,776

4,888

2,505

4,605

5,274

4,599

2,762

4,294

4,097

4,826

2,098

5,600

6,992

11,314

9,917

9,426

13,000

12,380

11,110

13,382

16,093

15,509

994

20,578

18,071

6,507

14,749

13,141

8,639

7,178

7,496

8,387

8,350

10,630

12,232

11,922

12,328

16,201

16,302

13,368

11,964

13,612

14,117

14,687

6,626

6,990

7,933

2,868

2,235

2,950

1,871

1,746

1,740

1,679

1,720

1,687

1,323

1,452

1,351

955

1,694

665

> Long-term Assets

0
0
8,531
0
9,336
9,351
9,427
9,501
9,383
9,965
10,299
13,490
14,130
14,844
19,760
25,398
256,061
255,420
258,381
258,392
256,314
266,865
270,535
268,828
265,962
260,105
256,596
256,006
253,944
252,565
250,569
248,537
246,832
243,116
239,742
237,754
235,558
565,799
557,771
627,484
650,031
650,309
655,919
653,917
652,043
647,921
642,493
635,884
625,844
617,810
611,764
608,813
604,112
581,809
574,429
564,368
559,267
554,047
549,619
545,311
541,860
537,440
572,986
641,003
635,055
521,146
524,007
592,903
602,915
442,599
441,521
438,817
436,588
420,559
424,442
421,918
415,492
409,406
406,281
399,377
390,275
369,095
318,474
314,155
126,655

126,655

314,155

318,474

369,095

390,275

399,377

406,281

409,406

415,492

421,918

424,442

420,559

436,588

438,817

441,521

442,599

602,915

592,903

524,007

521,146

635,055

641,003

572,986

537,440

541,860

545,311

549,619

554,047

559,267

564,368

574,429

581,809

604,112

608,813

611,764

617,810

625,844

635,884

642,493

647,921

652,043

653,917

655,919

650,309

650,031

627,484

557,771

565,799

235,558

237,754

239,742

243,116

246,832

248,537

250,569

252,565

253,944

256,006

256,596

260,105

265,962

268,828

270,535

266,865

256,314

258,392

258,381

255,420

256,061

25,398

19,760

14,844

14,130

13,490

10,299

9,965

9,383

9,501

9,427

9,351

9,336

8,531

Property Plant Equipment

2,730
0
6,261
6,875
7,161
7,343
7,450
7,558
7,773
8,528
8,895
9,712
10,355
10,802
10,612
10,842
14,369
16,832
18,882
19,242
19,919
21,163
22,253
22,715
22,600
22,183
22,327
22,600
23,293
24,193
24,092
24,102
23,714
23,804
23,485
23,196
23,148
55,915
57,525
58,547
61,187
62,650
63,748
66,390
66,478
67,208
66,844
67,553
58,295
54,560
52,799
51,153
49,693
48,284
47,230
47,116
46,180
45,234
44,353
43,767
43,058
42,461
42,163
41,945
41,207
24,258
25,334
27,508
28,182
28,312
29,427
29,628
29,827
37,073
41,133
43,090
43,594
45,005
46,189
45,957
45,559
44,384
43,356
42,557
37,040

37,040

42,557

43,356

44,384

45,559

45,957

46,189

45,005

43,594

43,090

41,133

37,073

29,827

29,628

29,427

28,312

28,182

27,508

25,334

24,258

41,207

41,945

42,163

42,461

43,058

43,767

44,353

45,234

46,180

47,116

47,230

48,284

49,693

51,153

52,799

54,560

58,295

67,553

66,844

67,208

66,478

66,390

63,748

62,650

61,187

58,547

57,525

55,915

23,148

23,196

23,485

23,804

23,714

24,102

24,092

24,193

23,293

22,600

22,327

22,183

22,600

22,715

22,253

21,163

19,919

19,242

18,882

16,832

14,369

10,842

10,612

10,802

10,355

9,712

8,895

8,528

7,773

7,558

7,450

7,343

7,161

6,875

6,261

2,730

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,626
153,787
154,341
154,430
154,430
162,707
164,522
164,540
161,990
161,974
161,974
161,974
161,974
161,974
161,974
161,964
161,959
161,951
161,951
161,951
161,951
313,975
307,171
337,190
356,692
355,440
359,736
359,736
359,736
360,294
361,215
360,473
360,473
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
382,992
426,874
423,674
347,666
347,666
360,094
359,093
201,515
200,943
201,117
201,102
201,316
201,491
201,709
201,484
201,058
201,038
200,755
199,976
159,238
159,017
159,226
0

159,226

159,017

159,238

199,976

200,755

201,038

201,058

201,484

201,709

201,491

201,316

201,102

201,117

200,943

201,515

359,093

360,094

347,666

423,674

426,874

382,992

361,252

360,473

361,215

360,294

359,736

355,440

356,692

337,190

307,171

313,975

161,951

161,959

161,964

161,974

161,990

164,540

164,522

162,707

154,430

154,341

153,787

169,626

Intangible Assets

1,157
0
1,036
975
945
964
934
901
870
839
808
3,127
3,095
3,565
8,534
8,457
50,795
49,148
48,655
48,026
47,203
71,311
72,759
70,548
70,065
67,770
65,491
63,033
60,738
58,352
56,093
53,948
53,770
48,037
45,705
43,691
41,530
143,568
143,538
212,303
219,238
214,848
216,355
212,195
207,970
205,256
201,745
197,362
186,547
181,806
177,399
172,511
168,080
167,577
162,342
154,439
150,078
145,675
141,583
137,437
134,512
130,310
144,194
168,706
166,564
145,387
141,655
196,325
201,956
197,136
194,318
190,559
186,216
168,977
168,893
165,000
159,105
152,380
147,976
141,943
134,011
111,144
106,671
103,891
81,570

81,570

103,891

106,671

111,144

134,011

141,943

147,976

152,380

159,105

165,000

168,893

168,977

186,216

190,559

194,318

197,136

201,956

196,325

141,655

145,387

166,564

168,706

144,194

130,310

134,512

137,437

141,583

145,675

150,078

154,439

162,342

167,577

168,080

172,511

177,399

181,806

186,547

197,362

201,745

205,256

207,970

212,195

216,355

214,848

219,238

212,303

143,538

143,568

41,530

43,691

45,705

48,037

53,770

53,948

56,093

58,352

60,738

63,033

65,491

67,770

70,065

70,548

72,759

71,311

47,203

48,026

48,655

49,148

50,795

8,457

8,534

3,565

3,095

3,127

808

839

870

901

934

964

945

975

1,036

1,157

Long-term Assets Other

0
0
408
0
404
402
401
400
98
97
95
94
94
91
90
5,299
6,356
6,364
8,223
9,599
9,270
4,824
3,802
3,931
875
908
3,798
5,187
5,298
2,557
2,777
5,925
5,751
3,489
3,674
4,046
3,765
11,906
10,934
10,166
5,646
6,123
5,307
5,543
5,592
5,397
3,950
3,260
4,060
5,288
4,818
4,071
5,524
4,696
3,605
1,561
1,757
1,886
2,431
2,855
3,038
3,417
3,637
3,478
3,610
3,835
9,352
8,976
13,684
15,636
16,833
17,513
19,443
13,193
12,925
12,119
11,309
-5,074
-4,037
-3,568
-2,761
54,329
9,430
8,481
8,045

8,045

8,481

9,430

54,329

-2,761

-3,568

-4,037

-5,074

11,309

12,119

12,925

13,193

19,443

17,513

16,833

15,636

13,684

8,976

9,352

3,835

3,610

3,478

3,637

3,417

3,038

2,855

2,431

1,886

1,757

1,561

3,605

4,696

5,524

4,071

4,818

5,288

4,060

3,260

3,950

5,397

5,592

5,543

5,307

6,123

5,646

10,166

10,934

11,906

3,765

4,046

3,674

3,489

5,751

5,925

2,777

2,557

5,298

5,187

3,798

908

875

3,931

3,802

4,824

9,270

9,599

8,223

6,364

6,356

5,299

400

401

402

404

408

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,927
4,870
5,164
39,198
38,603
9,278
7,268
11,007
10,227
9,507
11,721
10,403
9,236
7,236
16,469
14,904
15,496
19,826
19,563
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

19,563

19,826

15,496

14,904

16,469

7,236

9,236

10,403

11,721

9,507

10,227

11,007

7,268

9,278

38,603

39,198

5,164

4,870

4,927

> Total Liabilities

20,942
0
25,568
25,586
25,352
12,494
7,897
8,513
8,598
10,562
9,317
9,950
12,893
13,562
14,755
17,845
46,014
47,323
44,672
46,870
43,389
53,034
36,023
29,414
32,694
36,509
33,251
26,894
25,385
32,576
24,916
26,531
27,825
31,798
30,307
32,745
35,244
201,685
193,483
252,259
269,114
265,052
272,708
265,761
254,485
262,264
256,969
255,760
239,380
228,601
224,666
212,732
202,768
221,036
213,994
188,821
172,568
190,934
182,457
176,586
160,101
162,877
148,982
234,397
223,716
221,623
76,291
111,069
121,486
139,640
128,705
134,178
127,309
121,981
119,813
121,735
113,486
128,262
143,611
150,249
145,194
154,341
66,145
98,397
107,567

107,567

98,397

66,145

154,341

145,194

150,249

143,611

128,262

113,486

121,735

119,813

121,981

127,309

134,178

128,705

139,640

121,486

111,069

76,291

221,623

223,716

234,397

148,982

162,877

160,101

176,586

182,457

190,934

172,568

188,821

213,994

221,036

202,768

212,732

224,666

228,601

239,380

255,760

256,969

262,264

254,485

265,761

272,708

265,052

269,114

252,259

193,483

201,685

35,244

32,745

30,307

31,798

27,825

26,531

24,916

32,576

25,385

26,894

33,251

36,509

32,694

29,414

36,023

53,034

43,389

46,870

44,672

47,323

46,014

17,845

14,755

13,562

12,893

9,950

9,317

10,562

8,598

8,513

7,897

12,494

25,352

25,586

25,568

20,942

> Total Current Liabilities

5,777
0
6,165
6,253
6,064
9,394
4,837
5,493
5,618
7,627
6,427
7,105
10,093
10,807
8,545
11,680
15,714
20,418
37,262
39,625
36,229
41,334
24,345
22,484
25,884
29,699
26,506
20,214
18,770
26,026
18,431
20,121
21,480
25,523
24,107
26,620
29,194
59,185
51,379
60,385
66,830
63,735
74,363
69,079
63,380
72,244
64,246
57,937
59,687
61,157
60,651
60,104
61,579
67,096
65,431
50,752
50,641
69,516
64,323
59,660
54,403
57,301
45,789
49,702
53,295
73,302
47,172
57,005
48,712
51,534
39,846
45,812
50,256
57,584
52,097
54,475
49,368
74,324
66,390
73,567
69,632
83,825
57,452
78,037
85,874

85,874

78,037

57,452

83,825

69,632

73,567

66,390

74,324

49,368

54,475

52,097

57,584

50,256

45,812

39,846

51,534

48,712

57,005

47,172

73,302

53,295

49,702

45,789

57,301

54,403

59,660

64,323

69,516

50,641

50,752

65,431

67,096

61,579

60,104

60,651

61,157

59,687

57,937

64,246

72,244

63,380

69,079

74,363

63,735

66,830

60,385

51,379

59,185

29,194

26,620

24,107

25,523

21,480

20,121

18,431

26,026

18,770

20,214

26,506

29,699

25,884

22,484

24,345

41,334

36,229

39,625

37,262

20,418

15,714

11,680

8,545

10,807

10,093

7,105

6,427

7,627

5,618

5,493

4,837

9,394

6,064

6,253

6,165

5,777

Short-term Debt

0
0
140
0
150
3,155
160
160
160
165
174
175
180
180
180
180
300
315
9,950
10,040
10,040
10,040
340
315
350
265
245
250
255
260
260
270
270
275
285
290
295
7,500
7,500
15,555
16,621
16,707
25,829
17,221
17,146
21,341
16,047
16,045
17,368
18,719
19,986
21,025
25,153
29,169
30,553
14,440
14,531
14,625
14,638
7,060
7,080
7,100
8,973
9,006
12,923
12,135
878
889
889
836
0
0
30,000
0
0
0
0
8,783
8,892
2,491
9,877
14,761
4,729
1,652
0

1,652

4,729

14,761

9,877

2,491

8,892

8,783

30,000

836

889

878

12,135

12,923

9,006

8,973

7,100

7,080

7,060

14,638

14,625

14,531

14,440

30,553

29,169

25,153

21,025

19,986

18,719

17,368

16,045

16,047

21,341

17,146

17,221

25,829

16,707

16,621

15,555

7,500

295

290

285

275

270

260

255

250

245

265

350

315

340

10,040

9,950

315

300

180

175

174

165

160

3,155

150

140

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
143,215
0
0
0
9,007
0
0
0
16,250
17,500
5,000
5,000
5,000
95,147
5,000
5,000
5,000
5,000
5,000
6,250
7,500
0
0
0
0
0
0
0
0
0
0
0
8,783
8,892
0
9,877
14,761
4,729
0
0

4,729

14,761

9,877

8,892

8,783

7,500

6,250

5,000

95,147

5,000

17,500

16,250

9,007

143,215

Accounts payable

2,294
0
2,707
2,623
2,071
2,143
2,122
2,444
2,224
3,971
3,135
2,042
4,903
5,791
3,899
5,613
6,848
7,567
5,086
6,974
6,791
9,081
10,535
8,388
9,871
13,152
11,921
8,692
8,640
12,044
8,758
8,056
8,163
11,391
10,729
11,808
16,535
29,200
24,431
20,950
23,664
24,522
26,701
28,336
25,506
32,895
46,872
41,146
21,696
23,668
24,942
21,701
18,067
15,616
15,648
15,286
15,357
18,087
17,421
21,800
16,350
15,775
16,916
19,424
18,443
22,829
16,870
17,968
18,304
19,096
14,008
15,979
17,067
19,630
22,687
24,191
21,570
28,047
29,258
34,688
35,600
40,445
24,807
37,650
35,152

35,152

37,650

24,807

40,445

35,600

34,688

29,258

28,047

21,570

24,191

22,687

19,630

17,067

15,979

14,008

19,096

18,304

17,968

16,870

22,829

18,443

19,424

16,916

15,775

16,350

21,800

17,421

18,087

15,357

15,286

15,648

15,616

18,067

21,701

24,942

23,668

21,696

41,146

46,872

32,895

25,506

28,336

26,701

24,522

23,664

20,950

24,431

29,200

16,535

11,808

10,729

11,391

8,163

8,056

8,758

12,044

8,640

8,692

11,921

13,152

9,871

8,388

10,535

9,081

6,791

6,974

5,086

7,567

6,848

5,613

3,899

5,791

4,903

2,042

3,135

3,971

2,224

2,444

2,122

2,143

2,071

2,623

2,707

2,294

Other Current Liabilities

2,500
0
1,246
3,490
1,329
753
448
341
57
3,491
3,118
95
496
4,836
407
639
283
4,400
14,410
14,603
10,758
12,690
5,000
4,751
5,164
5,227
4,946
19,964
18,515
13,722
9,413
19,851
21,210
25,248
23,822
26,330
28,899
19,347
16,107
20,923
22,850
20,933
20,243
21,906
883
17,808
1,137
746
9,868
9,969
14,931
9,775
12,653
12,919
13,053
9,440
9,531
9,625
9,638
2,060
2,080
2,100
3,973
4,006
6,673
4,635
6,731
9,670
2,074
2,133
25,838
29,833
33,189
37,954
29,410
30,284
27,798
21,457
13,125
22,098
10,665
43,380
1,837
40,387
50,722

50,722

40,387

1,837

43,380

10,665

22,098

13,125

21,457

27,798

30,284

29,410

37,954

33,189

29,833

25,838

2,133

2,074

9,670

6,731

4,635

6,673

4,006

3,973

2,100

2,080

2,060

9,638

9,625

9,531

9,440

13,053

12,919

12,653

9,775

14,931

9,969

9,868

746

1,137

17,808

883

21,906

20,243

20,933

22,850

20,923

16,107

19,347

28,899

26,330

23,822

25,248

21,210

19,851

9,413

13,722

18,515

19,964

4,946

5,227

5,164

4,751

5,000

12,690

10,758

14,603

14,410

4,400

283

639

407

4,836

496

3,118

3,491

341

448

753

1,329

3,490

1,246

2,500

> Long-term Liabilities

0
0
19,403
0
19,288
3,100
3,060
3,020
2,980
2,935
2,890
2,845
2,800
2,755
6,210
6,165
30,300
26,905
7,410
7,245
7,160
11,700
11,678
6,930
6,810
6,810
6,745
6,680
6,615
6,550
6,485
6,410
6,345
6,275
6,200
6,125
6,050
142,500
142,104
191,874
202,284
201,317
198,345
196,682
191,105
190,020
192,723
197,823
179,693
167,444
164,015
152,628
141,189
153,940
148,563
138,069
121,927
121,418
118,134
116,926
105,698
105,576
103,193
184,695
170,421
148,321
29,119
54,064
72,774
88,106
88,859
88,366
77,053
64,397
67,716
67,260
64,118
53,938
77,221
76,682
75,562
70,516
8,693
20,360
21,693

21,693

20,360

8,693

70,516

75,562

76,682

77,221

53,938

64,118

67,260

67,716

64,397

77,053

88,366

88,859

88,106

72,774

54,064

29,119

148,321

170,421

184,695

103,193

105,576

105,698

116,926

118,134

121,418

121,927

138,069

148,563

153,940

141,189

152,628

164,015

167,444

179,693

197,823

192,723

190,020

191,105

196,682

198,345

201,317

202,284

191,874

142,104

142,500

6,050

6,125

6,200

6,275

6,345

6,410

6,485

6,550

6,615

6,680

6,745

6,810

6,930

11,678

11,700

7,160

7,245

7,410

26,905

30,300

6,165

6,210

2,755

2,800

2,845

2,890

2,935

2,980

3,020

3,060

3,100

19,288

19,403

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,200
6,125
6,050
142,500
140,625
138,750
136,875
135,000
129,375
135,160
133,910
137,660
136,410
148,910
141,410
128,910
126,410
122,660
113,910
105,160
100,652
110,163
92,519
91,320
90,147
88,973
87,798
86,621
85,444
139,266
126,837
124,407
0
0
14,341
40,000
40,000
40,000
30,000
20,000
0
25,000
25,000
25,000
49,798
49,796
0
49,818
0
0
0

49,818

49,796

49,798

25,000

20,000

30,000

40,000

14,341

124,407

126,837

139,266

85,444

86,621

87,798

88,973

90,147

91,320

92,519

110,163

100,652

105,160

113,910

122,660

126,410

128,910

141,410

148,910

136,410

137,660

133,910

135,160

129,375

135,000

136,875

138,750

140,625

142,500

6,050

6,125

6,200

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,927
4,870
5,164
39,198
38,603
9,278
7,268
11,007
10,227
9,507
11,721
10,403
9,236
7,236
16,469
14,904
15,496
19,826
19,563
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

19,563

19,826

15,496

14,904

16,469

7,236

9,236

10,403

11,721

9,507

10,227

11,007

7,268

9,278

38,603

39,198

5,164

4,870

4,927

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
3,500
13,100
9,790
0
0
0
4,625
4,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
327
1,479
53,124
65,409
66,317
67,769
60,356
56,029
56,497
55,167
47,767
37,137
37,415
36,486
28,849
26,160
26,264
24,665
4,156
4,104
3,986
1,957
1,947
1,938
18,955
17,749
45,429
43,584
23,914
25,630
50,873
50,709
39,552
40,681
40,730
39,113
37,078
36,048
42,260
33,740
24,202
27,423
23,396
22,672
17,382
5,751
0
0

5,751

17,382

22,672

23,396

27,423

24,202

33,740

42,260

36,048

37,078

39,113

40,730

40,681

39,552

50,709

50,873

25,630

23,914

43,584

45,429

17,749

18,955

1,938

1,947

1,957

3,986

4,104

4,156

24,665

26,264

26,160

28,849

36,486

37,415

37,137

47,767

55,167

56,497

56,029

60,356

67,769

66,317

65,409

53,124

1,479

327

4,688

4,625

9,790

13,100

3,500

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,201
1,166
1,166
1,146
1,146
1,146
1,146
1,119
1,119
1,119
1,119
21,684
23,246
23,750
25,304
26,112
26,030
26,006
15,962
17,173
17,154
17,696
17,834
14,542
14,367
24,586
24,013
24,057
23,817
23,018
22,371
19,955
0
17,994
16,961
16,037
15,115
14,290
0
12,813
0
0
0

12,813

14,290

15,115

16,037

16,961

17,994

19,955

22,371

23,018

23,817

24,057

24,013

24,586

14,367

14,542

17,834

17,696

17,154

17,173

15,962

26,006

26,030

26,112

25,304

23,750

23,246

21,684

1,119

1,146

1,166

1,201

> Total Stockholder Equity

0
0
1,488
2,956
3,720
37,232
40,733
41,859
45,237
49,110
52,018
54,288
57,334
123,438
127,003
131,269
331,266
335,958
340,368
345,950
353,550
355,713
359,947
363,537
367,885
372,194
376,029
380,739
386,910
391,349
395,435
399,452
405,574
405,748
409,301
410,845
411,363
523,392
524,509
526,688
527,357
526,830
528,445
529,729
537,689
537,893
540,326
543,570
543,756
545,022
547,123
547,639
550,745
507,027
512,717
523,349
531,750
517,027
517,884
521,220
538,328
542,595
544,889
549,563
554,079
614,815
614,073
613,810
610,475
455,872
455,054
454,343
454,936
439,457
435,950
432,368
429,692
424,489
414,041
407,958
397,655
378,296
427,804
401,226
215,995

215,995

401,226

427,804

378,296

397,655

407,958

414,041

424,489

429,692

432,368

435,950

439,457

454,936

454,343

455,054

455,872

610,475

613,810

614,073

614,815

554,079

549,563

544,889

542,595

538,328

521,220

517,884

517,027

531,750

523,349

512,717

507,027

550,745

547,639

547,123

545,022

543,756

543,570

540,326

537,893

537,689

529,729

528,445

526,830

527,357

526,688

524,509

523,392

411,363

410,845

409,301

405,748

405,574

399,452

395,435

391,349

386,910

380,739

376,029

372,194

367,885

363,537

359,947

355,713

353,550

345,950

340,368

335,958

331,266

131,269

127,003

123,438

57,334

54,288

52,018

49,110

45,237

41,859

40,733

37,232

3,720

2,956

1,488

Retained Earnings

0
0
-10,943
0
-9,346
-8,268
-7,507
-6,471
-5,386
-3,720
-2,427
-772
1,108
3,146
5,044
7,499
-8,907
-5,981
-3,601
-501
4,389
4,908
7,119
10,026
11,938
14,840
16,951
20,080
23,413
27,152
29,040
32,319
36,130
35,269
36,642
38,971
37,203
30,175
29,454
31,423
30,431
29,563
29,137
29,038
34,146
32,651
31,971
33,309
29,047
28,233
27,476
27,114
27,744
-16,015
-14,715
-981
1,906
-11,007
-11,240
-10,992
3,027
5,129
4,660
6,800
7,596
66,469
65,194
62,458
56,749
-100,318
-104,586
-108,854
-112,398
-131,866
-138,838
-147,189
-152,147
-158,413
-171,417
-179,903
-189,388
-210,855
-164,971
-194,019
0

-194,019

-164,971

-210,855

-189,388

-179,903

-171,417

-158,413

-152,147

-147,189

-138,838

-131,866

-112,398

-108,854

-104,586

-100,318

56,749

62,458

65,194

66,469

7,596

6,800

4,660

5,129

3,027

-10,992

-11,240

-11,007

1,906

-981

-14,715

-16,015

27,744

27,114

27,476

28,233

29,047

33,309

31,971

32,651

34,146

29,038

29,137

29,563

30,431

31,423

29,454

30,175

37,203

38,971

36,642

35,269

36,130

32,319

29,040

27,152

23,413

20,080

16,951

14,840

11,938

10,026

7,119

4,908

4,389

-501

-3,601

-5,981

-8,907

7,499

5,044

3,146

1,108

-772

-2,427

-3,720

-5,386

-6,471

-7,507

-8,268

-9,346

-10,943

Accumulated Other Comprehensive Income

0
0
-300
0
-203
-118
-173
-171
-169
-169
-154
-152
-155
-82
-68
-96
-112
-61
-60
-27
41
-36
-279
-861
-1,063
-905
-972
-1,015
-1,223
-1,394
-1,275
-1,402
-1,465
-1,273
-1,349
-1,596
-1,455
-1,274
-1,897
-1,702
-1,741
-1,534
-1,263
-1,522
-1,344
-1,269
-1,243
-1,345
-1,896
-1,568
-1,615
-1,922
-1,790
-791
-1,089
-1,653
-1,697
-1,324
-1,041
-846
-637
-952
-1,044
-1,250
-1,077
-1,352
-1,503
-1,272
-1,264
-1,341
754
1,934
1,946
3,153
3,743
4,562
3,526
1,357
807
-288
-3,850
-4,723
-5,653
-4,708
0

-4,708

-5,653

-4,723

-3,850

-288

807

1,357

3,526

4,562

3,743

3,153

1,946

1,934

754

-1,341

-1,264

-1,272

-1,503

-1,352

-1,077

-1,250

-1,044

-952

-637

-846

-1,041

-1,324

-1,697

-1,653

-1,089

-791

-1,790

-1,922

-1,615

-1,568

-1,896

-1,345

-1,243

-1,269

-1,344

-1,522

-1,263

-1,534

-1,741

-1,702

-1,897

-1,274

-1,455

-1,596

-1,349

-1,273

-1,465

-1,402

-1,275

-1,394

-1,223

-1,015

-972

-905

-1,063

-861

-279

-36

-27

-60

-61

-112

-96

-68

-82

-155

-152

-154

-169

-171

-173

-118

-203

-300

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
373,756
373,219
375,363
496,375
498,077
498,722
500,421
500,554
502,323
503,964
506,638
508,354
510,704
513,353
518,349
520,101
523,004
524,189
526,532
525,775
530,259
535,558
531,171
532,705
535,511
538,403
541,282
543,762
546,615
549,355
552,902
555,040
555,723
557,965
560,330
561,871
564,225
566,602
570,725
573,507
0
580,330
583,647
586,879
589,984
593,482
0
599,206
0
0
0

599,206

593,482

589,984

586,879

583,647

580,330

573,507

570,725

566,602

564,225

561,871

560,330

557,965

555,723

555,040

552,902

549,355

546,615

543,762

541,282

538,403

535,511

532,705

531,171

535,558

530,259

525,775

526,532

524,189

523,004

520,101

518,349

513,353

510,704

508,354

506,638

503,964

502,323

500,554

500,421

498,722

498,077

496,375

375,363

373,219

373,756

Treasury Stock

-5,714

-9,944

-2,104

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31	2006-05-31	2005-05-31	2004-05-31	2003-05-31	2002-05-31	2001-05-31
Accounts Payable	40,445	28,047	19,630	19,096	22,829	15,775	18,087	15,616	23,668	32,895	24,522	29,200	11,391	12,044	13,152	9,081	7,567	5,791	3,971	2,143	2,707	2,294	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Other Comprehensive Income	-4,723	1,357	3,153	-1,341	-1,352	-952	-1,324	-791	-1,568	-1,269	-1,534	-1,274	-1,273	-1,394	-905	-36	-61	-82	-169	-118	-300	-3,550	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Stock	382	380	377	374	372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Surpluse	599,206	586,879	573,507	561,871	555,040	543,762	532,705	525,775	520,101	508,354	0	496,375	0	0	0	0	0	0	0	0	0	0	-
Cash	44,620	28,825	48,161	54,435	227,641	74,096	47,544	32,333	18,391	16,105	21,802	23,508	45,984	58,763	27,909	32,040	28,313	64,042	14,498	1,747	939	1,525	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash And Short Term Investments	44,620	28,825	48,161	54,435	227,641	75,413	48,759	33,986	20,080	17,914	23,955	37,578	131,542	100,074	68,187	78,222	71,504	89,752	27,099	2,484	1,668	2,843	-
Common Stock	382	380	377	374	372	370	367	363	360	353	351	348	250	247	245	243	240	155	121	112	92	92	-
Common Stock Shares Outstanding	39,480	39,009	38,342	37,961	37,485	37,539	36,959	36,161	35,683	35,440	34,817	25,382	25,133	24,787	24,513	24,349	18,444	12,965	12,329	9,838	9,472	9,337	9,200
Common Stock Total Equity	382	380	377	374	372	370	367	363	360	353	351	348	250	247	245	243	200	200	100	112	92	92	-
Current Deferred Revenue	-14,761	16,037	-2,415	29,469	0	32,326	27,179	9,392	8,801	200	1,573	3,138	-11,391	-12,044	11,055	9,523	8,136	822	736	3,343	2,072	1,891	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	10,403	0	39,198	0	0	0	0	0	0	0	0	0	0	-
Deferred Long Term Liab	12,813	16,037	19,955	24,057	14,542	17,173	26,112	21,684	0	1,146	0	0	0	0	0	0	0	0	0	0	0	0	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Good Will	159,238	201,058	201,316	201,515	347,666	361,252	361,252	361,252	361,252	360,294	355,440	313,975	161,951	161,974	161,974	162,707	153,787	0	0	0	0	0	-
Intangible Assets	111,144	152,380	168,977	197,136	145,387	130,310	145,675	167,577	181,806	205,256	214,848	143,568	48,037	58,352	67,770	71,311	49,148	3,565	839	964	1,036	1,157	-
Inventory	55,325	51,392	48,614	59,905	40,071	48,916	54,506	55,370	67,388	61,056	55,062	55,823	28,062	29,216	36,928	22,901	28,569	15,968	10,264	8,545	8,631	7,909	-
Liabilities And Stockholders Equity	532,637	552,751	561,438	595,512	836,438	705,472	707,961	728,063	773,623	800,157	791,882	725,077	437,546	423,925	408,703	408,747	383,281	137,000	59,672	49,726	27,056	20,647	-
Long Term Debt	49,818	25,000	20,000	40,000	124,407	86,621	91,320	105,160	128,910	137,660	135,000	142,500	6,275	6,550	6,810	7,075	17,115	2,755	2,935	3,100	19,403	15,165	-
Long Term Debt Total	49,818	25,000	20,000	40,000	124,407	86,621	91,320	105,160	128,910	137,660	0	142,500	0	0	0	0	0	0	0	0	0	0	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Debt	5,198	4,958	-28,161	-13,599	-91,099	19,625	58,401	101,996	129,238	142,896	129,905	126,492	-39,434	-51,953	-20,834	-14,925	-10,883	-61,107	-11,398	4,508	18,604	14,623	-
Net Invested Capital	49,818	25,000	20,000	494,872	746,722	634,216	611,347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Receivables	52,826	52,304	35,405	31,263	43,577	39,401	44,523	52,867	58,428	62,155	48,090	51,088	27,365	29,838	27,181	26,642	20,798	13,486	9,929	27,894	6,532	4,461	-
Net Tangible Assets	378,296	71,051	69,164	57,221	121,762	51,033	8,100	-20,601	2,195	-28,894	0	67,342	0	0	0	0	0	0	0	0	0	0	-
Net Working Capital	79,717	69,021	83,295	101,468	241,990	110,731	82,398	79,158	94,656	79,992	77,838	100,093	168,907	145,334	118,899	100,548	107,443	111,349	42,080	30,981	12,360	10,101	-
Non Current Assets Total	369,095	409,406	420,559	442,599	521,146	537,440	554,047	581,809	617,810	647,921	650,309	565,799	243,116	252,565	260,105	266,865	255,420	14,844	9,965	9,351	8,531	4,769	-
Non Current Liabilities Other	7,885	12,901	24,442	23,840	9,372	1,782	3,986	26,264	0	56,497	0	327	0	0	0	0	0	0	0	0	0	0	-
Non Current Liabilities Total	70,516	53,938	64,397	88,106	148,321	105,576	121,418	153,940	167,444	190,020	201,317	142,500	6,275	6,550	6,810	11,700	26,905	2,755	2,935	3,100	19,403	15,165	-
Non Currrent Assets Other	54,329	-5,074	13,193	15,636	3,835	3,417	1,886	4,696	5,288	5,397	6,123	11,906	3,489	5,519	908	4,824	6,364	91	97	402	408	0	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Assets	49,216	10,963	3,811	5,192	3,835	113,234	1,886	3,827	24,906	14,850	17,112	45,438	9,324	8,046	8,178	11,684	35,653	477	598	1,044	1,234	882	-
Other Current Assets	4,617	2,201	1,760	2,238	2,203	2,505	2,762	2,098	9,917	11,110	994	14,749	7,496	12,232	16,302	14,117	6,990	2,950	1,679	1,452	1,694	665	-
Other Current Liab	43,380	21,457	37,954	2,133	38,338	2,100	9,625	12,919	9,969	17,808	20,933	19,347	25,248	25,766	5,227	12,690	4,400	4,836	3,491	753	1,246	609	-
Other Liab	17,382	24,202	37,078	39,552	23,914	18,955	30,098	47,948	38,534	56,497	66,317	327	0	0	0	4,625	9,790	0	0	0	0	0	-
Other Stockholder Equity	593,492	581,165	567,793	557,157	549,326	538,048	526,991	523,671	517,997	506,159	498,450	494,271	371,393	365,344	358,014	350,598	341,760	120,219	52,878	45,506	12,639	15,292	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Property Plant And Equipment Gross	44,384	96,074	37,073	28,312	24,258	42,461	45,234	48,284	54,560	67,208	62,650	55,915	23,804	24,193	22,183	21,163	16,800	10,800	8,500	7,343	6,261	2,730	-
Property Plant And Equipment Net	44,384	45,005	37,073	28,312	24,258	42,461	45,234	48,284	54,560	67,208	62,650	55,915	23,804	24,193	22,183	21,163	16,832	10,802	8,528	7,343	6,261	2,730	-
Property Plant Equipment	44,384	45,005	37,073	28,312	24,258	42,461	45,234	48,284	54,450	66,590	62,650	55,915	23,804	24,193	22,183	21,163	16,832	10,802	8,528	7,343	6,261	2,730	-
Retained Earnings	-210,855	-158,413	-131,866	-100,318	66,469	5,129	-11,007	-16,015	28,233	32,651	29,563	30,175	35,269	27,152	14,840	4,908	-5,981	3,146	-3,720	-8,268	-10,943	-12,129	-
Retained Earnings Total Equity	-210,855	-158,413	-131,866	-100,318	66,469	5,129	-11,007	-16,015	0	31,501	0	30,175	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt	14,761	8,783	0	836	7,500	5,000	5,000	16,250	9,007	143,215	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt Total	49,818	33,783	20,000	40,836	136,542	93,721	105,945	134,329	147,629	159,001	151,707	150,000	6,550	6,810	7,075	17,115	17,430	2,935	3,100	6,255	19,543	16,148	-
Short Term Debt	14,761	8,783	2,415	836	12,135	7,100	14,625	29,169	18,719	21,341	16,707	7,500	275	260	265	10,040	315	180	165	3,155	140	983	-
Short Term Investments	0	0	0	689	0	1,317	1,215	1,653	1,689	1,809	2,153	14,070	85,558	41,311	40,278	46,182	43,191	25,710	12,601	737	729	1,318	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Assets	532,637	552,751	561,438	595,512	836,438	705,472	707,961	728,063	773,623	800,157	791,882	725,077	437,546	423,925	408,703	408,747	383,281	137,000	59,672	49,726	27,056	20,647	-
Total Current Assets	163,542	143,345	140,879	152,913	315,292	168,032	153,914	146,254	155,813	152,236	141,573	159,278	194,430	171,360	148,598	141,882	127,861	122,156	49,707	40,375	18,525	15,878	-
Total Current Liabilities	83,825	74,324	57,584	51,534	73,302	57,301	69,516	67,096	61,157	72,244	63,735	59,185	25,523	26,026	29,699	41,334	20,418	10,807	7,627	9,394	6,165	5,777	-
Total Liab	154,341	128,262	121,981	139,640	221,623	162,877	190,934	221,036	228,601	262,264	265,052	201,685	31,798	32,576	36,509	53,034	47,323	13,562	10,562	12,494	25,568	20,942	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Stockholder Equity	378,296	424,489	439,457	455,872	614,815	542,595	517,027	507,027	545,022	537,893	526,830	523,392	405,748	391,349	372,194	355,713	335,958	123,438	49,110	37,232	1,488	-295	-
Treasury Stock	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-2,104	-2,104	-2,104	-2,104	-2,104	0	0	0	0	0	0	0	0	0	0	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-

	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28	2022-11-30	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2015-08-31	2015-05-31	2015-02-28	2014-11-30	2014-08-31	2014-05-31	2014-02-28	2013-11-30	2013-08-31	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29	2011-11-30	2011-08-31	2011-05-31	2011-02-28	2010-11-30	2010-08-31	2010-05-31	2010-02-28	2009-11-30	2009-08-31	2009-05-31	2009-02-28	2008-11-30	2008-08-31	2008-05-31	2008-02-29	2007-11-30	2007-08-31	2007-05-31	2007-02-28	2006-11-30	2006-08-31	2006-05-31	2006-02-28	2005-11-30	2005-08-31	2005-05-31	2005-02-28	2004-11-30	2004-08-31	2004-05-31	2004-02-29	2003-11-30	2003-05-31	2003-02-28	2002-05-31
Accounts Payable	35,152	37,650	24,807	40,445	35,600	34,688	29,258	28,047	21,570	24,191	22,687	19,630	17,067	15,979	14,008	19,096	18,304	17,968	16,870	22,829	18,443	19,424	16,916	15,775	16,350	21,800	17,421	18,087	15,357	15,286	15,648	15,616	18,067	21,701	24,942	23,668	21,696	41,146	46,872	32,895	25,506	28,336	26,701	24,522	23,664	20,950	24,431	29,200	16,535	11,808	10,729	11,391	8,163	8,056	8,758	12,044	8,640	8,692	11,921	13,152	9,871	8,388	10,535	9,081	6,791	6,974	5,086	7,567	6,848	5,613	3,899	5,791	4,903	2,042	3,135	3,971	2,224	2,444	2,122	2,143	2,071	2,623	2,707	0	2,294
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	0	-4,708	-5,653	-4,723	-3,850	-288	807	1,357	3,526	4,562	3,743	3,153	1,946	1,934	754	-1,341	-1,264	-1,272	-1,503	-1,352	-1,077	-1,250	-1,044	-952	-637	-846	-1,041	-1,324	-1,697	-1,653	-1,089	-791	-1,790	-1,922	-1,615	-1,568	-1,896	-1,345	-1,243	-1,269	-1,344	-1,522	-1,263	-1,534	-1,741	-1,702	-1,897	-1,274	-1,455	-1,596	-1,349	-1,273	-1,465	-1,402	-1,275	-1,394	-1,223	-1,015	-972	-905	-1,063	-861	-279	-36	41	-27	-60	-61	-112	-96	-68	-82	-155	-152	-154	-169	-169	-171	-173	-118	-203	0	-300	0	0
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	0	383	383	382	382	381	381	380	380	379	379	377	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	0	599,206	0	593,482	589,984	586,879	583,647	580,330	0	573,507	570,725	566,602	564,225	561,871	560,330	557,965	555,723	555,040	552,902	549,355	546,615	543,762	541,282	538,403	535,511	532,705	531,171	535,558	530,259	525,775	526,532	524,189	523,004	520,101	518,349	513,353	510,704	508,354	506,638	503,964	502,323	500,554	500,421	498,722	498,077	496,375	375,363	373,219	373,756	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	78,451	60,896	57,586	44,620	30,111	29,857	24,564	28,825	23,890	34,291	35,472	48,161	54,469	58,025	47,929	54,435	27,160	41,247	83,649	227,641	41,704	42,820	24,762	74,096	52,292	49,856	48,200	47,544	35,571	35,664	37,411	32,333	21,897	18,996	20,268	18,391	19,704	14,877	13,808	16,105	7,382	15,173	22,065	21,802	16,625	19,322	18,896	23,508	34,047	42,955	50,493	45,984	35,257	27,132	67,202	58,763	37,513	36,256	32,168	27,909	26,776	19,734	18,518	32,040	43,646	22,759	23,426	28,313	38,052	73,158	70,786	64,042	13,356	13,043	13,298	14,498	15,404	11,849	20,749	1,747	1,332	0	939	0	1,525
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	78,451	60,896	57,586	44,620	30,111	29,857	24,564	28,825	23,890	34,291	35,472	48,161	54,469	58,025	47,929	54,435	27,160	41,247	83,649	227,641	41,704	44,170	26,112	75,413	53,573	51,116	49,415	48,759	36,774	36,867	39,058	33,986	23,563	20,635	21,960	20,080	21,386	16,575	15,478	17,914	9,189	17,023	23,915	23,955	18,779	21,477	30,523	37,578	143,027	136,319	136,651	131,542	120,230	110,603	101,998	100,074	85,778	74,028	68,756	68,187	62,333	57,842	59,249	78,222	77,852	68,371	69,593	71,504	67,029	87,948	89,207	89,752	28,907	27,483	28,814	27,099	24,994	22,203	21,488	2,484	2,067	0	1,668	0	0
Common Stock	0	383	383	382	382	381	381	380	380	379	379	377	377	375	375	374	374	373	373	372	372	372	372	370	370	369	368	367	370	369	366	363	363	362	362	360	360	358	356	353	353	353	352	351	350	349	349	348	252	251	252	250	249	248	248	247	247	246	246	245	245	244	244	243	242	241	240	240	239	157	155	155	124	123	122	121	118	115	114	112	92	92	92	0	92
Common Stock Shares Outstanding	40,234	40,219	39,968	39,608	39,509	39,490	39,302	39,160	39,092	39,053	38,734	38,525	38,360	38,327	38,157	38,072	37,999	37,992	37,783	38,285	37,518	38,117	37,323	37,747	37,442	37,383	36,919	36,655	37,126	37,146	36,698	36,242	36,390	36,140	35,960	35,918	35,755	36,127	35,885	35,278	35,704	35,132	34,950	34,906	34,834	35,311	34,704	26,193	25,129	25,340	25,197	25,261	25,174	25,094	25,032	25,032	24,867	24,729	24,590	24,590	24,484	24,563	24,474	24,474	24,450	23,846	23,800	23,800	18,642	16,360	15,852	15,852	13,429	12,731	12,857	12,857	12,056	11,511	11,790	11,790	9,757	0	9,314	9,314	0
Common Stock Total Equity	0	0	0	382	0	381	381	380	380	379	379	377	377	375	375	374	374	373	373	372	372	372	372	370	370	369	368	367	370	369	366	363	363	362	362	360	360	358	356	353	353	353	352	351	350	349	349	348	252	251	252	250	249	248	248	247	247	246	246	245	245	244	244	243	242	241	240	200	200	200	200	200	100	100	100	100	100	100	100	112	92	0	92	0	0
Current Deferred Revenue	0	-1,652	26,079	-14,761	13,490	14,290	15,115	16,037	0	0	0	0	0	0	0	29,469	27,445	28,478	22,693	33,703	15,256	17,266	15,927	32,326	28,893	28,740	22,626	27,179	11,222	11,586	6,177	9,392	5,706	7,603	792	8,801	10,755	0	190	200	19,845	1,616	1,590	1,573	3,695	2,957	3,341	3,138	-16,535	-11,808	-10,729	-11,391	-8,163	-8,056	0	0	-8,640	-8,692	9,394	11,055	10,499	9,030	8,470	9,523	8,640	8,008	7,816	8,136	8,283	5,248	4,059	822	4,514	4,793	736	736	3,177	2,548	2,107	3,343	2,514	0	2,072	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19,563	19,826	15,496	14,904	16,469	7,236	9,236	10,403	11,721	9,507	10,227	11,007	7,268	9,278	38,603	39,198	5,164	4,870	4,927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	0	12,813	0	14,290	15,115	16,037	16,961	17,994	0	19,955	22,371	23,018	23,817	24,057	24,013	24,586	14,367	14,542	17,834	17,696	17,154	17,173	15,962	26,006	26,030	26,112	25,304	23,750	23,246	21,684	1,119	1,119	1,119	1,119	1,146	1,146	1,146	1,146	1,166	1,166	1,201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	0	159,226	159,017	159,238	199,976	200,755	201,038	201,058	201,484	201,709	201,491	201,316	201,102	201,117	200,943	201,515	359,093	360,094	347,666	347,666	423,674	426,874	382,992	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	361,252	360,473	360,473	361,215	360,294	359,736	359,736	359,736	355,440	356,692	337,190	307,171	313,975	161,951	161,951	161,951	161,951	161,959	161,964	161,974	161,974	161,974	161,974	161,974	161,974	161,990	164,540	164,522	162,707	154,430	154,430	154,341	153,787	169,626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	81,570	103,891	106,671	111,144	134,011	141,943	147,976	152,380	159,105	165,000	168,893	168,977	186,216	190,559	194,318	197,136	201,956	196,325	141,655	145,387	166,564	168,706	144,194	130,310	134,512	137,437	141,583	145,675	150,078	154,439	162,342	167,577	168,080	172,511	177,399	181,806	186,547	197,362	201,745	205,256	207,970	212,195	216,355	214,848	219,238	212,303	143,538	143,568	41,530	43,691	45,705	48,037	53,770	53,948	56,093	58,352	60,738	63,033	65,491	67,770	70,065	70,548	72,759	71,311	47,203	48,026	48,655	49,148	50,795	8,457	8,534	3,565	3,095	3,127	808	839	870	901	934	964	945	975	1,036	0	1,157
Inventory	58,068	64,254	59,972	55,325	63,532	63,177	57,609	51,392	48,039	48,183	49,305	48,614	49,006	49,582	52,762	59,905	54,898	50,239	45,229	40,071	52,388	50,637	49,721	48,916	56,564	54,032	55,425	54,506	57,681	56,667	58,274	55,370	65,792	70,813	74,327	67,388	68,710	75,315	70,416	61,056	59,834	60,052	59,249	55,062	61,973	62,330	63,414	55,823	28,158	29,427	29,672	28,062	29,489	32,731	33,517	29,216	34,115	39,874	44,344	36,928	32,415	28,584	28,199	22,901	25,324	27,527	30,754	28,569	27,328	18,687	18,421	15,968	13,137	10,705	10,998	10,264	9,388	9,045	9,216	8,545	8,986	9,285	8,631	0	7,909
Liabilities And Stockholders Equity	323,562	499,623	493,949	532,637	542,849	558,207	557,652	552,751	543,178	554,103	555,763	561,438	582,245	588,521	583,759	595,512	731,961	724,879	690,364	836,438	777,795	783,960	693,871	705,472	698,429	697,806	700,341	707,961	704,318	712,170	726,711	728,063	753,513	760,371	771,789	773,623	783,136	799,330	797,295	800,157	792,174	795,490	801,153	791,882	796,471	778,947	717,992	725,077	446,607	443,590	439,608	437,546	433,399	425,983	420,351	423,925	412,295	407,633	409,280	408,703	400,579	392,951	395,970	408,747	396,939	392,820	385,040	383,281	377,280	149,114	141,758	137,000	70,227	64,238	61,335	59,672	53,835	50,372	48,630	49,726	29,072	0	27,056	0	0
Long Term Debt	0	0	0	49,818	49,807	49,796	49,798	25,000	25,000	25,000	25,000	20,000	30,000	40,000	40,000	40,000	14,341	0	0	124,407	126,837	139,266	85,444	86,621	87,798	88,973	90,147	91,320	92,519	110,163	100,652	105,160	113,910	122,660	126,410	128,910	141,410	148,910	136,410	137,660	133,910	135,160	129,375	135,000	136,875	138,750	140,625	142,500	6,050	6,125	6,200	6,275	6,345	6,410	6,485	6,550	6,615	6,680	6,745	6,810	6,810	6,930	6,990	7,075	7,160	7,245	7,410	17,115	17,200	2,665	2,710	2,755	2,800	2,845	2,890	2,935	2,980	3,020	3,060	3,100	19,288	19,333	19,403	0	15,165
Long Term Debt Total	0	0	0	49,818	0	49,796	49,798	25,000	25,000	25,000	0	20,000	30,000	40,000	40,000	40,000	14,341	0	0	124,407	126,837	139,266	85,444	86,621	87,798	88,973	90,147	91,320	92,519	110,163	100,652	105,160	113,910	122,660	126,410	128,910	141,410	148,910	136,410	137,660	133,910	135,160	129,375	135,000	136,875	138,750	140,625	142,500	6,050	6,125	6,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	-78,451	-56,676	-52,857	5,198	29,573	19,939	34,126	4,958	1,110	-9,291	-10,472	-28,161	-24,469	-18,025	-7,929	-13,599	-11,930	-40,358	-82,771	-91,099	98,056	105,452	69,655	19,625	42,586	46,177	56,585	58,401	71,479	88,939	93,794	101,996	117,166	124,689	126,128	129,238	139,074	150,078	138,649	142,896	143,674	137,208	133,139	129,905	136,871	134,983	130,708	126,492	-27,702	-36,540	-44,008	-39,434	-28,642	-20,452	-60,457	-51,953	-30,643	-29,326	-25,178	-20,834	-19,616	-12,489	-11,188	-14,925	-26,446	-5,474	-6,066	-10,883	-20,552	-70,313	-67,896	-61,107	-10,376	-10,023	-10,234	-11,398	-12,264	-8,669	-17,529	4,508	18,106	0	18,604	0	0
Net Invested Capital	0	401,226	432,533	49,818	457,339	49,796	49,798	25,000	454,692	457,368	460,950	20,000	484,936	494,343	495,054	494,872	624,816	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	49,475	51,603	49,755	52,826	50,892	52,852	53,586	52,304	41,810	38,205	35,416	35,405	33,171	33,604	33,590	31,263	35,619	33,994	32,540	43,577	44,208	43,374	40,164	39,401	41,827	42,073	41,283	44,523	46,302	50,171	50,124	52,867	54,446	53,118	52,424	58,428	57,770	58,556	56,257	62,155	57,726	48,405	46,561	48,090	45,110	49,585	47,928	51,088	26,723	31,451	26,365	27,365	28,461	25,762	23,637	29,838	26,536	25,397	23,383	27,181	26,501	25,733	24,375	26,642	22,762	22,216	19,686	20,798	18,929	14,213	12,135	13,486	12,182	10,814	9,484	9,929	8,350	7,936	7,176	27,894	7,332	0	6,532	0	0
Net Tangible Assets	0	0	162,116	378,296	63,668	65,260	65,027	71,051	69,103	65,659	65,566	69,164	67,618	62,667	59,793	57,221	49,426	57,391	124,752	121,762	-36,159	-46,017	17,703	51,033	42,564	22,531	15,049	8,100	20,420	7,658	-10,877	-20,601	21,413	13,876	8,472	1,964	-3,264	-14,264	-22,229	-28,894	-30,017	-42,202	-47,646	-43,476	-48,573	-22,805	73,170	67,342	207,882	205,203	201,645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	111,033	107,431	118,023	79,717	82,942	85,263	84,981	69,021	78,318	77,710	79,224	83,295	95,401	103,892	102,392	101,468	80,334	74,971	119,185	241,990	89,445	93,255	75,096	110,731	102,166	92,835	86,399	84,398	94,410	97,050	86,851	79,158	87,822	91,454	99,374	94,656	97,605	105,509	90,556	79,992	76,751	72,494	70,871	77,838	79,610	91,078	108,842	100,093	181,855	179,216	175,759	168,907	165,087	157,325	151,351	145,334	139,581	131,413	126,178	118,899	108,733	101,639	101,090	100,548	104,396	94,803	89,397	107,443	105,505	112,036	113,453	111,349	46,004	43,643	44,609	42,080	38,834	35,378	34,366	30,981	13,672	0	12,360	0	0
Non Current Assets Total	126,655	314,155	318,474	369,095	390,275	399,377	406,281	409,406	415,492	421,918	424,442	420,559	436,588	438,817	441,521	442,599	602,915	592,903	524,007	521,146	635,055	641,003	572,986	537,440	541,860	545,311	549,619	554,047	559,267	564,368	574,429	581,809	604,112	608,813	611,764	617,810	625,844	635,884	642,493	647,921	652,043	653,917	655,919	650,309	650,031	627,484	557,771	565,799	235,558	237,754	239,742	243,116	246,832	248,537	250,569	252,565	253,944	256,006	256,596	260,105	265,962	268,828	270,535	266,865	256,314	258,392	258,381	255,420	256,061	25,398	19,760	14,844	14,130	13,490	10,299	9,965	9,383	9,501	9,427	9,351	9,336	0	8,531	0	0
Non Current Liabilities Other	0	2,602	7,414	7,885	12,265	12,596	12,308	12,901	22,157	24,266	24,319	24,442	24,682	25,348	25,042	23,840	34,420	29,478	14,752	9,372	25,750	27,733	595	1,782	1,938	1,947	1,957	3,986	4,104	4,156	24,665	26,264	26,160	28,849	36,486	37,415	37,137	47,767	55,167	56,497	56,029	60,356	67,769	66,317	65,409	53,124	1,479	327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	21,693	20,360	8,693	70,516	75,562	76,682	77,221	53,938	64,118	67,260	67,716	64,397	77,053	88,366	88,859	88,106	72,774	54,064	29,119	148,321	170,421	184,695	103,193	105,576	105,698	116,926	118,134	121,418	121,927	138,069	148,563	153,940	141,189	152,628	164,015	167,444	179,693	197,823	192,723	190,020	191,105	196,682	198,345	201,317	202,284	191,874	142,104	142,500	6,050	6,125	6,200	6,275	6,345	6,410	6,485	6,550	6,615	6,680	6,745	6,810	6,810	6,930	11,678	11,700	7,160	7,245	7,410	26,905	30,300	6,165	6,210	2,755	2,800	2,845	2,890	2,935	2,980	3,020	3,060	3,100	19,288	0	19,403	0	0
Non Currrent Assets Other	8,045	8,481	9,430	54,329	-2,761	-3,568	-4,037	-5,074	11,309	12,119	12,925	13,193	19,443	17,513	16,833	15,636	13,684	8,976	9,352	3,835	3,610	3,478	3,637	3,417	3,038	2,855	2,431	1,886	1,757	1,561	3,605	4,696	5,524	4,071	4,818	5,288	4,060	3,260	3,950	5,397	5,592	5,543	5,307	6,123	5,646	10,166	10,934	11,906	3,765	4,046	3,674	3,489	5,751	5,925	2,777	2,557	5,298	5,187	3,798	908	875	3,931	3,802	4,824	9,270	9,599	8,223	6,364	6,356	5,299	90	91	94	94	95	97	98	400	401	402	404	0	408	0	0
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	0	4,846	49,216	10,729	4,974	11,078	10,963	3,715	12,119	4,152	3,811	9,498	8,092	6,843	5,192	4,056	4,373	4,248	3,835	3,610	3,478	3,637	3,417	498,802	501,544	505,266	508,813	513,087	517,252	527,199	532,525	554,419	557,660	558,965	563,250	567,549	568,333	575,015	580,579	585,565	587,527	592,171	587,418	588,844	568,937	500,246	506,616	212,410	214,558	216,257	219,312	223,118	224,435	226,477	228,372	230,651	233,406	234,269	237,922	243,362	246,113	248,282	245,702	236,395	239,150	239,499	238,588	241,692	14,556	9,148	4,042	3,775	3,778	1,404	1,437	1,610	1,943	1,977	2,008	2,175	2,256	2,270	0	2,039
Other Current Assets	10,913	8,715	8,162	4,617	8,039	12,944	15,612	2,201	13,947	11,506	11,128	1,760	9,011	8,493	7,957	2,238	11,369	6,496	4,939	2,203	4,440	4,776	4,888	2,505	4,605	5,274	4,599	2,762	4,294	4,097	4,826	2,098	5,600	6,992	11,314	9,917	9,426	13,000	12,380	11,110	13,382	16,093	15,509	994	20,578	18,071	6,507	14,749	13,141	8,639	7,178	7,496	8,387	8,350	10,630	12,232	11,922	12,328	16,201	16,302	13,368	11,964	13,612	14,117	14,687	1	6,626	6,990	7,933	2,868	2,235	2,950	1,871	1,746	1,740	1,679	1,720	1,687	1,323	1,452	1,351	955	1,694	0	665
Other Current Liab	50,722	40,387	1,837	43,380	10,665	22,098	13,125	21,457	27,798	30,284	29,410	37,954	33,189	29,833	25,838	2,133	2,074	9,670	6,731	4,635	6,673	4,006	3,973	2,100	2,080	2,060	9,638	9,625	9,531	9,440	13,053	12,919	12,653	9,775	14,931	9,969	9,868	746	1,137	17,808	883	21,906	20,243	20,933	22,850	20,923	16,107	19,347	28,899	26,330	23,822	25,248	21,210	19,851	9,413	13,722	18,515	19,964	4,946	5,227	5,164	4,751	5,000	12,690	10,758	14,603	14,410	4,400	283	639	407	4,836	496	95	3,118	3,491	57	341	448	753	1,329	3,490	1,246	0	2,500
Other Liab	0	0	5,751	17,382	22,672	23,396	27,423	24,202	33,740	42,260	36,048	37,078	39,113	40,730	40,681	39,552	50,709	50,873	25,630	23,914	43,584	45,429	17,749	18,955	1,938	1,947	1,957	3,986	4,104	4,156	24,665	26,264	26,160	28,849	36,486	37,415	37,137	47,767	55,167	56,497	56,029	60,356	67,769	66,317	65,409	53,124	1,479	327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,688	4,625	0	0	0	9,790	13,100	3,500	3,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Stockholder Equity	215,995	401,226	427,804	378,296	590,511	587,768	584,270	581,165	577,933	574,616	570,666	567,793	565,011	560,888	558,511	556,157	554,616	552,251	550,009	549,326	547,188	543,641	540,901	538,048	535,568	532,689	529,797	526,991	531,171	525,614	528,155	523,671	524,428	522,085	520,900	517,997	516,245	511,249	508,600	506,159	504,534	501,860	500,219	498,450	498,317	496,618	495,973	494,271	375,363	373,219	373,756	371,393	370,660	368,287	367,422	365,344	364,473	361,428	359,804	358,014	356,765	354,128	352,863	350,598	348,878	346,237	343,789	341,760	340,046	123,709	121,872	120,219	56,257	55,089	54,477	52,878	50,674	48,386	48,299	45,506	13,177	0	12,639	0	0
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	0	0	0	44,384	0	0	0	0	0	0	41,133	37,073	29,827	29,628	29,427	28,312	28,182	27,508	25,334	24,258	41,207	41,945	42,163	42,461	43,058	43,767	44,353	45,234	46,180	47,116	47,230	48,284	49,693	51,153	52,799	54,560	58,295	67,552	66,794	67,208	66,478	66,390	63,748	62,650	61,187	58,547	57,525	55,915	23,148	23,196	23,485	23,804	23,714	24,102	24,092	24,193	23,293	22,600	22,327	22,183	22,600	22,715	22,253	21,163	19,919	19,242	16,832	16,800	14,400	10,800	10,600	10,800	10,400	9,700	8,900	8,500	7,800	7,600	7,500	7,343	7,161	0	6,261	0	0
Property Plant And Equipment Net	37,040	42,557	43,356	44,384	45,559	45,957	46,189	45,005	43,594	43,090	41,133	37,073	29,827	29,628	29,427	28,312	28,182	27,508	25,334	24,258	41,207	41,945	42,163	42,461	43,058	43,767	44,353	45,234	46,180	47,116	47,230	48,284	49,693	51,153	52,799	54,560	58,295	67,553	66,844	67,208	66,478	66,390	63,748	62,650	61,187	58,547	57,525	55,915	23,148	23,196	23,485	23,804	23,714	24,102	24,092	24,193	23,293	22,600	22,327	22,183	22,600	22,715	22,253	21,163	19,919	19,242	18,882	16,832	14,369	10,842	10,612	10,802	10,355	9,712	8,895	8,528	7,773	7,558	7,450	7,343	7,161	0	6,261	0	0
Property Plant Equipment	0	0	47,940	44,384	45,559	45,957	46,189	45,005	43,594	43,090	49,906	37,073	39,772	29,628	29,427	28,312	28,182	27,508	25,334	24,258	41,207	41,945	42,163	42,461	43,058	43,767	44,353	45,234	46,180	47,116	47,230	48,284	49,693	51,153	52,799	54,560	58,295	67,552	66,794	66,590	66,478	66,390	63,748	62,650	61,187	58,547	57,525	55,915	23,148	23,196	23,485	23,804	23,714	24,102	24,092	24,193	23,293	22,600	22,327	22,183	22,600	22,715	22,253	21,163	19,919	19,242	18,882	16,832	14,369	10,842	10,612	10,802	10,355	9,712	8,895	8,528	7,773	7,558	7,450	7,343	7,161	6,875	6,261	0	2,730
Retained Earnings	0	-194,019	-164,971	-210,855	-189,388	-179,903	-171,417	-158,413	-152,147	-147,189	-138,838	-131,866	-112,398	-108,854	-104,586	-100,318	56,749	62,458	65,194	66,469	7,596	6,800	4,660	5,129	3,027	-10,992	-11,240	-11,007	1,906	-981	-14,715	-16,015	27,744	27,114	27,476	28,233	29,047	33,309	31,971	32,651	34,146	29,038	29,137	29,563	30,431	31,423	29,454	30,175	37,203	38,971	36,642	35,269	36,130	32,319	29,040	27,152	23,413	20,080	16,951	14,840	11,938	10,026	7,119	4,908	4,389	-501	-3,601	-5,981	-8,907	7,499	5,044	3,146	1,108	-772	-2,427	-3,720	-5,386	-6,471	-7,507	-8,268	-9,346	0	-10,943	0	0
Retained Earnings Total Equity	0	0	0	-210,855	0	-179,903	-171,417	-158,413	-152,147	-147,189	0	-131,866	-112,398	-108,854	-104,586	-100,318	56,749	62,458	65,194	66,469	7,596	6,800	4,660	5,129	3,027	-10,992	-11,240	-11,007	1,906	-981	-14,715	-16,015	27,744	27,114	27,476	28,233	29,047	33,309	31,971	31,501	34,146	29,038	29,137	29,563	30,431	31,423	29,454	30,175	37,203	38,971	36,642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	0	0	4,729	14,761	9,877	0	8,892	8,783	0	0	0	0	0	0	0	0	0	0	0	7,500	6,250	5,000	5,000	5,000	5,000	5,000	95,147	5,000	5,000	5,000	17,500	16,250	0	0	0	9,007	0	0	0	143,215	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	0	4,220	4,729	49,818	59,684	49,796	58,690	33,783	25,000	25,000	25,000	20,000	30,000	40,000	40,000	40,836	15,230	889	878	136,542	139,760	148,272	94,417	93,721	94,878	96,033	104,785	105,945	107,050	124,603	131,205	134,329	139,063	143,685	146,396	147,629	158,778	164,955	152,457	159,001	151,056	152,381	155,204	151,707	153,496	154,305	149,604	150,000	6,345	6,415	6,485	6,550	6,615	6,680	6,745	6,810	6,870	6,930	6,990	7,075	7,160	7,245	7,330	17,115	17,200	17,285	17,360	17,430	17,500	2,845	2,890	2,935	2,980	3,020	3,064	3,100	3,140	3,180	3,220	6,255	19,438	0	19,543	0	0
Short Term Debt	0	1,652	4,729	14,761	9,877	2,491	8,892	8,783	0	0	0	0	30,000	0	0	836	889	889	878	12,135	12,923	9,006	8,973	7,100	7,080	7,060	14,638	14,625	14,531	14,440	30,553	29,169	25,153	21,025	19,986	18,719	17,368	16,045	16,047	21,341	17,146	17,221	25,829	16,707	16,621	15,555	7,500	7,500	295	290	285	275	270	270	260	260	255	250	245	265	350	315	340	10,040	10,040	10,040	9,950	315	300	180	180	180	180	175	174	165	160	160	160	3,155	150	0	140	0	0
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,350	1,350	1,317	1,281	1,260	1,215	1,215	1,203	1,203	1,647	1,653	1,666	1,639	1,692	1,689	1,682	1,698	1,670	1,809	1,807	1,850	1,850	2,153	2,154	2,155	11,627	14,070	108,980	93,364	86,158	85,558	84,973	83,471	34,796	41,311	48,265	37,772	36,588	40,278	35,557	38,108	40,731	46,182	34,206	45,612	46,167	43,191	28,977	14,790	18,421	25,710	15,551	14,440	15,516	12,601	9,590	10,354	739	737	735	0	729	0	1,318
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	323,562	499,623	493,949	532,637	542,849	558,207	557,652	552,751	543,178	554,103	555,763	561,438	582,245	588,521	583,759	595,512	731,961	724,879	690,364	836,438	777,795	783,960	693,871	705,472	698,429	697,806	700,341	707,961	704,318	712,170	726,711	728,063	753,513	760,371	771,789	773,623	783,136	799,330	797,295	800,157	792,174	795,490	801,153	791,882	796,471	778,947	717,992	725,077	446,607	443,590	439,608	437,546	433,399	425,983	420,351	423,925	412,295	407,633	409,280	408,703	400,579	392,951	395,970	408,747	396,939	392,820	385,040	383,281	377,280	149,114	141,758	137,000	70,227	64,238	61,335	59,672	53,835	50,372	48,630	49,726	29,072	28,542	27,056	0	20,647
Total Current Assets	196,907	185,468	175,475	163,542	152,574	158,830	151,371	143,345	127,686	132,185	131,321	140,879	145,657	149,704	142,238	152,913	129,046	131,976	166,357	315,292	142,740	142,957	120,885	168,032	156,569	152,495	150,722	153,914	145,051	147,802	152,282	146,254	149,401	151,558	160,025	155,813	157,292	163,446	154,802	152,236	140,131	141,573	145,234	141,573	146,440	151,463	160,221	159,278	211,049	205,836	199,866	194,430	186,567	177,446	169,782	171,360	158,351	151,627	152,684	148,598	134,617	124,123	125,435	141,882	140,625	134,428	126,659	127,861	121,219	123,716	121,998	122,156	56,097	50,748	51,036	49,707	44,452	40,871	39,203	40,375	19,736	0	18,525	0	0
Total Current Liabilities	85,874	78,037	57,452	83,825	69,632	73,567	66,390	74,324	49,368	54,475	52,097	57,584	50,256	45,812	39,846	51,534	48,712	57,005	47,172	73,302	53,295	49,702	45,789	57,301	54,403	59,660	64,323	69,516	50,641	50,752	65,431	67,096	61,579	60,104	60,651	61,157	59,687	57,937	64,246	72,244	63,380	69,079	74,363	63,735	66,830	60,385	51,379	59,185	29,194	26,620	24,107	25,523	21,480	20,121	18,431	26,026	18,770	20,214	26,506	29,699	25,884	22,484	24,345	41,334	36,229	39,625	37,262	20,418	15,714	11,680	8,545	10,807	10,093	7,105	6,427	7,627	5,618	5,493	4,837	9,394	6,064	6,253	6,165	0	5,777
Total Liab	107,567	98,397	66,145	154,341	145,194	150,249	143,611	128,262	113,486	121,735	119,813	121,981	127,309	134,178	128,705	139,640	121,486	111,069	76,291	221,623	223,716	234,397	148,982	162,877	160,101	176,586	182,457	190,934	172,568	188,821	213,994	221,036	202,768	212,732	224,666	228,601	239,380	255,760	256,969	262,264	254,485	265,761	272,708	265,052	269,114	252,259	193,483	201,685	35,244	32,745	30,307	31,798	27,825	26,531	24,916	32,576	25,385	26,894	33,251	36,509	32,694	29,414	36,023	53,034	43,389	46,870	44,672	47,323	46,014	17,845	14,755	13,562	12,893	9,950	9,317	10,562	8,598	8,513	7,897	12,494	25,352	25,586	25,568	0	20,942
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	215,995	401,226	427,804	378,296	397,655	407,958	414,041	424,489	429,692	432,368	435,950	439,457	454,936	454,343	455,054	455,872	610,475	613,810	614,073	614,815	554,079	549,563	544,889	542,595	538,328	521,220	517,884	517,027	531,750	523,349	512,717	507,027	550,745	547,639	547,123	545,022	543,756	543,570	540,326	537,893	537,689	529,729	528,445	526,830	527,357	526,688	524,509	523,392	411,363	410,845	409,301	405,748	405,574	399,452	395,435	391,349	386,910	380,739	376,029	372,194	367,885	363,537	359,947	355,713	353,550	345,950	340,368	335,958	331,266	131,269	127,003	123,438	57,334	54,288	52,018	49,110	45,237	41,859	40,733	37,232	3,720	2,956	1,488	0	0
Treasury Stock	0	0	0	-5,714	0	-5,714	-5,714	-5,714	-5,714	-5,714	0	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	-5,714	0	-9,944	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	-2,104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31	2006-05-31	2005-05-31	2004-05-31	2003-05-31	2002-05-31
Begin Period Cash Flow	28,825	48,161	54,435	227,641	74,096	47,544	32,333	18,391	16,105	21,802	23,508	45,984	58,763	27,909	32,040	28,313	64,042	14,498	1,747	939	1,525	663
Capital Expenditures	4,352	4,297	13,711	7,585	3,118	3,656	3,001	5,594	13,293	11,771	11,530	2,492	4,043	10,453	21,439	6,711	7,339	6,076	1,825	1,635	4,062	682
Cash And Cash Equivalents Changes	15,752	-18,818	-6,274	-173,206	153,545	26,552	15,211	13,942	2,286	-5,697	-1,706	-22,476	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	505	-6,281	-5,530	-5,653	-8,556	-10,178	908	40,695	-6,111	3,598	8,746	-4,963	0	0	0	0	0	0	0	0	0	0
Change In Cash	15,795	-19,336	-6,274	-173,206	153,545	26,552	15,211	13,942	2,286	-5,697	-1,706	-22,476	-12,779	30,854	-4,131	3,727	-35,729	49,544	12,751	808	-586	862
Change In Working Capital	-7,026	-21,047	9,072	-28,549	-1,264	2,460	22,860	12,964	-10,936	-10,021	-7,278	-2,237	3,774	5,904	-6,568	-8,886	-9,621	-7,490	-2,795	-2,046	-2,118	-487
Change Receivables	-1,299	-17,151	-4,162	11,918	-3,177	5,044	8,479	3,131	2,095	-14,786	1,141	-2,496	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-1,299	-17,151	-4,162	11,918	-3,177	5,044	8,479	3,131	2,095	-14,863	977	-2,496	2,770	-2,613	351	-6,134	-7,300	-3,827	-1,914	0	0	0
Change To Inventory	-8,198	-2,796	11,539	-18,845	-1,428	5,740	687	11,976	-6,154	-5,447	-2,397	-1,091	1,559	8,302	-10,532	4,172	-6,522	-5,887	-1,719	86	-722	-2,555
Change To Liabilities	2,139	3,912	4,876	-15,467	5,212	-7,093	19,214	-2,956	-6,254	6,658	-10,039	6,673	0	1,522	5,566	2,340	0	2,673	2,600	264	118	1,848
Change To Netincome	28,500	11,051	23,002	156,475	-41,831	8,276	-3,362	7,845	15,065	3,996	4,332	4,705	0	0	0	33	900	0	0	100	0	0
Change To Operating Activities	332	-5,012	-3,181	-6,155	-1,871	-1,231	-3,520	712	-1,170	1,208	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	30,873	29,349	25,916	23,805	25,880	23,163	24,811	28,379	30,492	25,050	29,069	13,044	12,579	12,459	12,055	8,869	3,409	1,082	771	681	657	569
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	44,620	28,825	48,161	54,435	227,641	74,096	47,544	32,333	18,391	16,105	21,802	23,508	45,984	58,763	27,909	32,040	28,313	64,042	14,498	1,747	939	1,525
Exchange Rate Changes	0	0	330	-65	-380	472	0	-42	-198	86	-65	49	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-4,274	-11,491	10,382	-22,139	34,322	37,631	52,744	39,622	12,949	13,513	14,764	8,337	29,827	29,506	-1,497	19,196	1,445	-2,857	2,963	865	-3,382	524
Investments	-9,746	-11,410	-8,524	-63,345	1,350	-3,656	450	25	25	328	11,855	70,499	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	24,249	5,000	-20,000	-93,275	40,000	-5,000	-25,274	-16,250	-5,000	-517	-7,500	141,072	0	0	0	0	0	0	0	0	0	0
Net Income	-52,442	-26,547	-31,548	-165,787	61,340	16,335	7,008	-44,451	-3,268	3,088	-614	-5,094	8,117	12,312	9,932	10,889	-9,127	6,866	4,548	3,143	1,186	1,009
Other Cashflows From Financing Activities	69,249	10,000	-16,986	38,017	46,900	-6,551	115,955	-7,413	9,535	132,233	1,214	148,874	2,182	2,983	1,774	-224	5,950	-383	15,845	-696	3,306	371
Other Cashflows From Investing Activities	-5,934	-15,010	-8,524	-56,110	84,322	-1,265	169,242	-5,268	-1,353	-5,604	-21,973	-244,367	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	19,825	4,067	16,833	149,953	-55,110	364	-9,545	5,342	9,067	-1,414	794	1,550	5,631	-1,469	-5,537	4,650	5,059	2,758	2,145	665	910	60
Sale Purchase Of Stock	0	0	0	-759	2,031	2,949	-13,557	2,437	5,757	2,444	1,214	14	0	0	0	0	4,580	65,810	5,660	0	0	0
Stock Based Compensation	11,158	10,692	8,625	7,592	9,249	7,912	6,183	3,240	5,998	5,412	4,609	4,090	4,609	4,876	5,793	4,902	21,882	21	0	0	0	0
Total Cash From Financing Activities	25,420	7,683	-16,986	-95,242	33,931	-11,551	-37,983	-23,663	-10,465	-14,017	-6,286	142,338	1,922	2,718	-8,266	4,014	10,529	65,422	21,500	-696	3,306	371
Total Cash From Operating Activities	78	-7,194	24,093	-14,554	37,440	41,287	55,745	45,216	26,242	25,284	26,294	10,829	33,870	39,959	19,942	25,907	8,784	3,219	4,788	2,500	680	1,206
Total Cashflows From Investing Activities	-9,746	-19,307	-13,711	-63,345	82,554	-3,656	-2,551	-7,569	-12,736	-16,448	-22,238	-176,360	0	0	0	0	0	0	0	0	0	0

	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28	2022-11-30	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2015-08-31	2015-05-31	2015-02-28	2014-11-30	2014-08-31	2014-05-31	2014-02-28	2013-11-30	2013-08-31	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29	2011-11-30	2011-08-31	2011-05-31	2011-02-28	2010-11-30	2010-08-31	2010-05-31	2010-02-28	2009-11-30	2009-08-31	2009-05-31	2009-02-28	2008-11-30	2008-08-31	2008-05-31	2008-02-29	2007-11-30	2007-08-31	2007-05-31	2007-02-28	2006-11-30	2006-08-31	2006-05-31	2006-02-28	2005-11-30	2005-08-31	2005-05-31	2005-02-28	2004-11-30	2004-08-31	2004-05-31	2004-02-29	2003-11-30	2003-08-31	2003-05-31	2003-02-28	2002-11-30	2002-08-31	2002-05-31	2002-02-28	2001-11-30
Begin Period Cash Flow	60,896	57,586	44,620	30,111	29,857	24,564	28,825	23,890	34,291	35,472	48,161	54,469	58,025	47,929	54,435	27,160	41,247	83,649	227,641	41,704	42,820	24,762	74,096	52,292	49,856	48,200	47,544	35,571	35,664	37,411	32,333	21,897	18,996	20,268	18,391	19,704	14,877	13,808	16,105	7,382	15,173	22,065	21,802	16,625	19,321	18,896	23,508	34,047	42,955	50,493	45,984	35,257	27,132	67,202	58,763	37,513	36,256	32,168	27,909	26,776	19,734	18,518	32,040	43,646	22,759	23,426	28,313	38,052	73,158	70,786	64,042	13,356	13,043	13,298	14,498	15,404	11,849	20,749	1,747	1,332	0	0	-	0	0	-	-	0	-	-
Capital Expenditures	607	554	791	1,056	666	1,281	1,349	1,039	1,106	1,131	1,021	9,144	1,382	1,361	1,824	1,479	1,742	2,823	1,541	815	887	734	682	744	1,690	721	501	743	412	1,365	481	3,681	745	425	743	1,251	4,269	2,515	2,441	2,768	1,842	3,508	3,833	3,822	2,921	3,819	968	113	1,021	817	541	987	1,567	827	662	1,717	1,435	6,371	930	889	2,911	5,756	11,883	1,552	2,221	2,245	3,797	2,837	2,374	538	1,590	3,633	874	1,010	559	931	371	265	258	302	1,333	895	0	4,062	0	0	0	682	0	0
Cash And Cash Equivalents Changes	0	0	0	0	0	5,106	-3,945	0	0	0	0	0	0	0	-6,506	27,275	-14,087	-42,402	-143,992	185,937	-1,116	18,058	-49,334	21,804	2,436	1,656	656	11,973	-93	-1,747	5,078	10,436	2,901	-1,272	1,877	-1,313	4,827	1,069	-2,297	8,723	-7,791	-6,892	263	5,177	-2,697	426	-4,612	-10,539	-8,908	-7,538	4,509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Cash Flows Other Operating	0	0	0	0	0	2,429	-5,112	0	0	0	0	0	0	0	-2,893	2,158	-5,171	-1,894	-746	-7,048	-325	17	-1,200	-9,630	155	-1,323	620	2,123	-747	401	-869	40,936	1,359	354	-1,954	-3,792	1,393	-876	-2,836	4,392	-511	-612	329	2,927	2,075	900	2,844	556	-3,323	-1,803	-393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Change In Cash	17,555	3,310	12,966	14,509	254	5,293	-4,261	4,935	-10,401	-1,181	-12,689	-6,308	-3,556	10,096	-6,506	27,275	-14,087	-42,402	-143,992	185,937	-1,116	18,058	-49,334	21,804	2,436	1,656	656	11,973	-93	-1,747	5,078	10,436	2,901	-1,272	1,877	-1,313	4,827	1,069	-2,297	8,723	-7,791	-6,892	263	5,177	-2,696	426	-4,612	-10,539	-8,908	-7,538	4,509	10,727	8,125	-40,070	8,439	21,250	1,257	4,088	4,259	1,133	7,042	1,216	-13,522	-11,606	20,887	-667	-4,887	-9,739	-35,106	2,372	6,744	50,686	313	-255	-1,200	-906	3,555	-8,900	19,002	415	0	0	-	0	0	-	-	0	-	-
Change In Working Capital	21,559	8,012	-22,124	11,970	628	2,762	-22,386	3,755	-13,660	-737	-10,405	10,343	652	7,182	-9,105	5,034	-20,660	-865	-12,058	17,135	-3,111	664	-15,952	11,821	-7,096	1,988	-4,253	21,167	1,816	3,448	-3,571	13,989	1,611	1,233	-3,869	1,752	8,174	-14,436	-8,817	1,724	-10,622	-660	-881	7,810	-746	239	-14,871	-507	5,437	-4,392	-2,775	5,683	2,160	1,057	-5,126	7,737	2,491	2,238	-6,562	3,990	-421	-3,116	-7,021	-5,726	1,492	1,653	-6,305	-12,544	4,167	801	-2,045	-5,110	-321	-1,153	-906	-1,086	-783	-287	-639	-481	0	0	-	0	0	-	-	0	-	-
Change Receivables	0	0	0	0	0	406	-1,425	0	0	0	0	0	0	0	-2,706	4,084	-1,630	-2,010	11,474	676	-785	-2,506	-562	2,147	598	-804	3,103	1,581	3,855	221	2,822	639	-2,416	-1,017	5,925	-1,440	466	-2,746	5,815	-5,093	-9,590	-1,961	1,858	-2,786	2,430	-1,698	3,195	-2,868	4,887	-5,237	722	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Change To Account Receivables	1,668	-2,480	3,157	-2,058	1,778	406	-1,425	-10,710	-3,519	-2,886	-36	-2,339	458	425	-2,706	4,084	-1,630	-2,010	11,474	676	-785	-2,506	-562	2,147	598	-804	3,103	1,581	3,855	221	2,822	639	-2,416	-1,017	5,925	-1,440	466	-2,746	5,995	-5,170	-9,590	-1,961	1,858	-2,980	2,454	-1,698	3,195	-2,868	4,887	-5,237	722	1,330	-2,717	-2,049	6,206	-3,326	-1,103	-2,014	3,830	-847	1,198	2,010	3,544	0	0	0	965	-1,900	1,982	-2,292	1,313	-1,489	-1,435	-1,355	452	-1,493	-431	-787	797	0	0	0	-	0	0	-	-	0	-	-
Change To Inventory	2,019	-4,270	-4,574	4,056	-423	-5,593	-6,238	-3,384	110	1,148	-670	420	591	3,281	7,247	-4,809	-4,027	-4,856	-5,153	1,274	-1,747	-194	-761	7,653	-2,511	1,379	-781	3,272	-1,027	1,491	-3,049	10,519	4,930	3,449	-6,922	1,322	6,605	-4,894	-9,365	-1,222	143	-878	-3,490	6,911	644	1,084	-10,653	-814	1,269	181	-1,727	1,646	3,390	558	-4,035	5,132	5,937	4,398	-7,165	-4,088	-3,268	-1,062	-2,114	2,291	1,900	2,674	-2,693	-1,788	-2,015	-266	-2,453	-3,014	-2,432	293	-734	-875	-344	171	-671	441	0	0	-	0	0	-	-	0	-	-
Change To Liabilities	0	0	-16,539	0	-4,266	6,147	-8,990	15,714	-7,288	1,831	-6,345	6,622	2,101	6,240	-10,087	2,536	-9,169	8,799	-17,633	15,548	-254	3,347	-13,429	2,704	-5,338	2,736	-7,195	20,619	-265	1,335	-2,475	1,777	-2,262	-1,553	-918	551	-290	-5,905	-233	3,959	-589	2,133	1,155	95	-3,273	-49	-6,812	3,216	2,565	2,509	-1,617	0	0	0	0	1,522	0	0	0	5,566	1,704	0	387	2,340	0	0	0	0	0	834	0	2,673	1,820	0	0	2,600	589	179	0	264	0	35	-	118	0	-	-	1,848	-	-
Change To Netincome	0	0	-56,347	-56,347	2,389	4,778	2,985	3,404	2,421	3,750	1,476	14,800	2,384	2,098	705	150,723	1,429	2,731	1,592	-51,033	3,790	3,463	1,949	13,027	-8,326	2,044	1,531	-2,045	3,493	-8,368	3,558	1,058	3,174	1,511	2,102	7,263	-458	3,637	4,623	151	-1,619	3,687	1,777	-2,212	2,866	2,631	1,047	2,132	-285	1,320	1,538	0	0	0	0	0	0	0	0	0	0	0	0	33	0	0	0	900	283	639	407	0	496	95	0	0	0	76	45	100	0	0	-	0	0	-	-	0	-	-
Change To Operating Activities	0	0	-4,168	-4,168	3,539	1,802	-5,733	2,135	-2,963	-830	-3,354	5,640	-2,498	-2,764	-3,559	3,223	-5,834	-2,798	-746	-363	-325	17	-1,200	1,230	-2,356	-725	620	-3,520	-747	401	-869	712	0	0	0	-1,170	0	0	0	1,208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Depreciation	7,522	6,685	6,688	7,557	7,838	7,818	7,660	7,667	7,406	7,279	6,997	6,524	6,379	6,436	6,577	6,255	6,440	5,903	5,207	6,722	6,867	6,692	5,599	5,768	5,718	5,884	5,793	6,356	6,169	6,133	6,153	6,980	6,979	7,197	7,223	7,716	8,777	7,314	7,266	6,140	6,549	6,263	6,097	6,653	6,810	6,292	9,314	3,583	3,188	3,141	3,132	3,467	3,128	2,955	3,029	3,271	3,037	3,140	3,079	3,182	3,091	2,877	2,905	2,507	2,315	2,135	1,912	1,870	1,031	383	125	326	263	268	225	208	189	191	183	152	0	0	-	0	0	-	-	0	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
End Period Cash Flow	78,451	60,896	57,586	44,620	30,111	29,857	24,564	28,825	23,890	34,291	35,472	48,161	54,469	58,025	47,929	54,435	27,160	41,247	83,649	227,641	41,704	42,820	24,762	74,096	52,292	49,856	48,200	47,544	35,571	35,664	37,411	32,333	21,897	18,996	20,268	18,391	19,704	14,877	13,808	16,105	7,382	15,173	22,065	21,802	16,625	19,322	18,896	23,508	34,047	42,955	50,493	45,984	35,257	27,132	67,202	58,763	37,513	36,256	32,168	27,909	26,776	19,734	18,518	32,040	43,646	22,759	23,426	28,313	38,052	73,158	70,786	64,042	13,356	13,043	13,298	14,498	15,404	11,849	20,749	1,747	1,332	0	-	0	0	-	-	0	-	-
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	252	-73	-68	244	-168	-260	160	-146	-134	-362	239	-64	659	0	-32	-174	-84	69	49	-152	-8	238	-395	-41	0	0	82	0	4	-22	-55	7	5	51	16	-28	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Free Cash Flow	-13,133	4,712	-26,690	14,898	704	6,218	-26,094	7,521	-9,897	810	-9,925	3,055	4,489	10,087	-7,249	2,401	-19,579	3,114	-8,075	24,197	7,455	12,225	-9,555	23,027	2,625	9,444	2,535	18,250	13,953	13,582	6,959	14,863	11,649	9,154	3,956	9,555	7,963	-4,662	248	7,340	-2,426	4,950	3,467	6,957	7,079	7,311	-6,582	-1,786	5,768	1,852	2,503	10,910	8,780	9,061	1,076	14,428	9,998	4,871	209	6,013	4,032	-1,330	-10,212	7,327	7,632	7,530	-3,293	2,510	-3,955	3,902	-1,012	-5,150	1,481	-66	878	860	1,349	722	32	1,058	-193	-115	-	-3,382	0	-	-	524	-	-
Investments	0	-1,793	98,442	-1,528	-2,146	-2,496	-2,227	-2,734	-2,593	-2,718	-4,471	-8,524	-1,382	-1,361	-1,824	-1,479	-11,742	-48,583	-1,541	168,427	1,350	1,350	1,350	1,350	0	0	0	450	0	450	450	25	0	25	0	25	0	0	0	328	25	0	303	0	0	9,452	2,403	94,560	-15,684	-7,634	-743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Net Borrowings	0	0	-50,000	-50,000	-50,000	-45	25,000	25,000	25,000	25,000	5,000	-10,000	-10,000	-10,000	-10,000	25,000	14,966	15,000	-133,241	-1,250	-11,250	53,750	-1,250	-1,250	-1,250	-1,250	-1,250	-1,279	-17,879	-3,616	-2,500	-5,000	-7,500	-2,500	-1,250	-11,250	-6,250	13,750	-1,250	3,750	-1,250	-3,017	0	-1,875	-1,875	-1,875	-1,875	141,277	-70	-70	-65	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Net Income	-190,439	-29,048	45,884	-21,467	-9,485	-8,486	-13,004	-6,266	-4,958	-8,351	-6,972	-19,468	-3,544	-4,268	-4,268	-156,067	-5,709	-2,736	-1,275	58,873	796	2,140	-469	2,102	14,019	249	-35	-10,913	2,887	13,734	1,300	-43,962	630	-362	-757	-814	-4,262	1,338	629	-1,078	5,108	-99	-426	-869	-992	1,969	-721	-7,028	-1,768	2,329	1,373	-861	3,811	3,279	1,888	3,739	3,333	3,129	2,111	2,902	1,912	2,907	2,211	519	4,890	3,100	2,380	2,926	-16,406	2,455	1,898	2,038	1,880	1,655	1,293	1,666	1,085	1,036	761	1,546	683	606	308	533	317	226	110	347	347	342
Other Cashflows From Financing Activities	694	-1,793	-10,000	91,171	45,000	-45	69,294	329	966	942	5,446	555	1,978	-10	491	24,947	15,560	-48,583	-3,249	-5,992	1,169	55,149	-1,395	389	822	-6,474	-1,288	400	3,707	111,145	703	504	703	-7,799	-821	144	3,510	7,022	-1,141	3,889	-4,222	132,838	-272	118	620	-103	579	145,562	1,062	-1,658	1,804	170	1,294	-132	850	49	1,963	397	574	9	535	-85	-9,785	-24	-80	-54	-66	-77	6,068	104	-262	-263	-40	-40	-40	19,909	-40	-20,004	15,980	-591	0	0	-	0	0	-	-	0	-	-
Other Cashflows From Investing Activities	0	0	0	0	0	0	-540	0	0	0	0	0	0	0	0	-55,760	-10,000	-45,960	-150	169,242	169,242	-47,920	-37,000	0	-1,265	0	0	0	0	0	0	-3,250	-2,018	0	0	-349	-754	-96	-154	-1,255	-30	-150	-4,169	1	-7,665	-15,166	858	-245,367	500	700	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Other Non Cash Items	158,360	1,374	-49,076	15,471	813	2,673	868	1,088	931	1,311	737	15,191	871	644	127	147,026	1,192	1,952	-217	-56,560	1,274	367	-191	786	-340	102	-184	474	246	-10,574	309	2,682	1,300	689	671	1,516	5,878	556	106	982	-4,211	995	820	-347	2,016	-882	-373	1,464	116	366	-396	5,678	-52	152	-147	-740	-504	-150	-143	-6,286	-2,176	1,796	98	7,893	-1,629	1,761	325	1,728	1,521	1,105	89	1,229	533	230	678	1,003	1,229	47	-15	143	0	0	-	0	0	-	-	0	-	-
Sale Purchase Of Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-759	594	-1,300	-1,300	8	1,169	149	705	389	822	926	-5,717	-5,717	3,865	-7,840	2,803	504	703	-49	1,279	144	3,510	1,144	959	236	1,075	455	678	118	620	-103	579	2,118	1,062	-1,658	1,804	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	670	670	2,780	740	117	63,830	770	350	860	1,210	1,360	90	22,940	0	0	0	-	0	0	-	-	0	-	-
Stock Based Compensation	2,612	1,877	4,144	2,981	1,803	3,350	3,024	2,903	2,352	3,008	2,429	2,227	2,147	2,387	1,864	1,594	1,772	2,242	1,984	2,130	2,378	2,591	2,150	2,091	2,058	1,966	1,797	1,105	1,693	1,701	1,684	-1,260	1,640	1,234	1,626	1,609	1,488	1,506	1,395	1,390	1,599	1,271	1,152	1,237	997	1,252	1,122	1,092	1,121	1,078	799	1,207	1,148	1,035	1,219	1,204	1,259	1,226	1,187	1,285	4,333	6	1,200	0	-11	2	1,211	9,790	12,085	-20	643	0	0	0	155	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-
Total Cash From Financing Activities	694	-352	-59,590	-180,000	941	103	24,376	329	966	942	5,446	-9,445	-8,022	-10	491	24,947	15,560	0	-135,749	-7,242	-10,081	53,899	-2,645	-861	-428	-7,724	-2,538	-6,567	-14,014	-15,605	-1,797	-4,496	-6,797	-10,299	-2,071	-11,106	-2,740	5,772	-2,391	2,639	-5,472	-10,912	-272	-1,757	-1,255	-1,978	-1,296	141,335	992	-1,728	1,739	105	1,229	-197	785	-11	1,903	337	489	-76	535	-80	-8,645	1,005	1,408	929	672	591	8,849	849	240	63,564	729	314	815	1,178	1,321	29	18,972	-591	0	0	-	3,306	0	-	-	371	-	-
Total Cash From Operating Activities	-12,526	5,266	-25,899	15,954	1,370	7,499	-24,745	8,560	-8,791	1,941	-8,904	12,199	5,871	11,448	-5,425	3,880	-17,837	5,937	-6,534	25,012	8,342	12,959	-8,873	23,771	4,315	10,165	3,036	18,993	14,365	14,947	7,440	18,544	12,394	9,579	4,699	10,806	12,232	-2,147	2,689	10,108	-584	8,458	7,300	10,779	10,000	11,130	-5,614	-1,673	6,789	2,669	3,044	11,897	10,347	9,888	1,738	16,145	11,433	11,242	1,139	6,902	6,943	4,426	1,671	5,775	9,853	9,775	504	5,347	-1,581	4,440	578	-1,517	2,355	944	1,437	1,791	1,720	987	290	1,360	1,140	780	-	680	0	-	-	1,206	-	-
Total Cashflows From Investing Activities	0	0	98,442	98,442	-2,146	-2,496	-3,576	-3,773	-2,593	-3,849	-9,092	-9,144	-1,382	-1,361	-1,824	-1,479	-11,742	-48,583	-1,541	168,427	463	-48,654	-37,682	-744	-1,690	-721	-501	-743	-412	-915	-481	-3,681	-2,745	-400	-743	-1,251	-4,269	-2,515	-5,258	-3,424	-1,817	-4,438	-6,769	-4,412	-11,387	-8,732	2,293	-150,920	-16,705	-8,451	-284	0	0	0	5,875	0	0	0	2,716	0	0	0	0	0	0	0	0	0	0	3,009	5,926	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-

Income Statement

Currency in USD. All numbers in thousands.

	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31	2006-05-31	2005-05-31	2004-05-31	2003-05-31	2002-05-31	2001-05-31
Cost Of Revenue	164,506	150,487	134,222	113,885	167,612	167,410	173,474	179,721	180,085	174,594	173,037	95,829	90,111	89,066	74,989	63,913	46,060	32,930	26,912	23,254	18,572	15,333	12,418
Depreciation And Amortization	30,873	29,349	25,916	23,805	25,880	23,163	24,811	28,379	30,492	25,050	29,069	13,044	12,579	12,459	12,055	8,869	3,409	1,082	771	681	657	569	9,836
Discontinued Operations	0	0	0	0	72,486	22,562	12,060	12,060	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Ebit	-19,233	-19,007	-14,870	-14,167	72,919	26,209	35,465	27,731	35,814	31,532	37,488	31,686	27,736	22,123	17,663	20,579	-11,539	10,144	7,991	5,123	3,238	2,388	-290
Ebitda	11,640	10,342	11,046	9,638	98,799	49,372	60,276	56,110	66,306	56,582	66,557	44,730	40,315	34,582	29,718	29,448	-8,130	11,226	8,762	5,804	3,895	2,957	9,546
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Extraordinary Items	0	0	0	0	72,486	29,962	12,060	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Gross Profit	174,246	165,732	156,788	150,272	191,872	176,875	176,169	173,969	176,889	179,861	168,989	125,958	125,846	126,969	120,065	102,587	66,167	45,521	33,377	25,801	19,862	15,557	10,972
Income Before Tax	-54,437	-29,949	-36,052	-167,135	59,469	7,465	11,847	-4,355	-7,999	6,380	-645	-5,282	10,842	19,619	15,152	17,328	-7,172	11,122	7,618	4,381	2,255	1,570	-1,170
Income Tax Expense	-1,995	-3,402	-4,504	-1,348	-1,871	-8,870	4,839	40,096	-4,731	3,292	-31	-188	2,616	7,307	5,220	6,439	1,955	4,256	3,069	1,238	1,069	561	-1,513
Interest Expense	2,702	688	861	907	5,099	3,062	2,839	3,396	3,197	3,656	5,271	508	499	672	731	1,328	0	138	150	0	0	0	0
Interest Income	0	0	0	907	5,099	3,062	2,839	3,385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Income	-52,442	-26,547	-31,548	-165,787	61,340	16,335	7,008	-44,451	-3,268	3,088	-614	-5,094	8,226	12,312	9,932	10,889	-9,127	6,866	4,548	3,143	1,186	1,009	343
Net Income Applicable To Common Shares	-52,442	-26,547	-31,548	-166,787	61,340	16,335	5,008	-43,590	-3,388	2,666	-612	-5,094	8,117	12,312	9,932	10,889	0	6,866	4,548	3,143	1,186	1,009	-
Net Income From Continuing Ops	-52,442	-26,547	-31,548	-166,787	-11,146	16,335	5,008	-43,590	-3,388	2,666	-612	-5,094	0	0	0	0	0	0	0	0	0	0	-
Net Interest Income	-2,702	-688	-861	-907	-5,099	-3,062	-2,839	-3,385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Non Operating Income Net Other	-554	-790	92	-1,037	-5,306	-3,093	-3,120	-4,271	-7,005	-7,200	-7,737	-2,320	0	0	0	0	0	0	0	0	0	0	-
Non Recurring	32,502	10,254	20,321	153,061	8,351	15,682	12,249	13,539	18,404	8,952	15,383	0	0	0	0	0	0	0	0	0	0	0	-
Operating Income	-19,233	-19,007	-14,870	-14,167	21,435	10,558	14,967	653	-994	13,448	7,094	-2,962	12,107	20,871	16,104	16,236	-11,225	10,306	7,727	5,123	3,238	2,388	-290
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Operating Expenses	357,431	334,436	305,972	278,194	332,950	318,045	324,427	339,498	339,564	331,965	319,735	208,585	196,668	195,164	178,950	150,264	123,452	68,145	52,562	43,932	35,196	28,502	13,844
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Reconciled Depreciation	30,873	29,349	25,916	23,805	25,880	23,163	24,811	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Research Development	29,883	30,739	36,390	29,682	29,435	25,459	25,269	25,126	26,931	27,510	26,319	20,511	21,372	19,275	17,914	14,424	20,555	5,869	4,570	3,551	2,509	1,951	1,426
Selling And Marketing Expenses	104,249	95,301	81,306	78,634	80,958	77,276	78,819	84,911	80,623	83,200	76,121	64,505	58,123	60,923	56,785	46,047	31,605	21,399	16,000	0	0	0	-
Selling General Administrative	40,003	38,451	35,918	37,872	35,173	31,265	31,406	29,206	29,871	26,035	26,127	18,334	17,828	16,437	20,136	15,425	44,800	7,801	5,100	17,127	14,115	11,218	-
Tax Provision	-1,995	-3,402	-4,504	-1,348	-3,556	-8,870	4,839	40,337	-4,743	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Operating Expenses	192,925	183,949	171,750	164,309	165,338	150,635	150,953	159,777	159,479	157,371	146,698	112,756	106,557	106,098	103,961	86,351	77,392	35,215	25,650	20,678	16,624	13,169	1,426
Total Other Income Expense Net	-35,204	-10,942	-21,182	-152,968	-13,450	-15,713	-13,369	-18,547	-25,409	-16,110	-22,936	-18,484	-8,447	-1,252	-1,780	-4,343	314	162	-264	-742	-983	-818	-880
Total Revenue	338,752	316,219	291,010	264,157	359,484	344,285	349,643	353,690	356,974	354,455	342,026	221,787	215,957	216,035	195,054	166,500	112,227	78,451	60,289	49,055	38,434	30,890	23,390

	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28	2022-11-30	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2015-08-31	2015-05-31	2015-02-28	2014-11-30	2014-08-31	2014-05-31	2014-02-28	2013-11-30	2013-08-31	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29	2011-11-30	2011-08-31	2011-05-31	2011-02-28	2010-11-30	2010-08-31	2010-05-31	2010-02-28	2009-11-30	2009-08-31	2009-05-31	2009-02-28	2008-11-30	2008-08-31	2008-05-31	2008-02-29	2007-11-30	2007-08-31	2007-05-31	2007-02-28	2006-11-30	2006-08-31	2006-05-31	2006-02-28	2005-11-30	2005-08-31	2005-05-31	2005-02-28	2004-11-30	2004-08-31	2004-05-31	2004-02-29	2003-11-30	2003-08-31	2003-05-31	2003-02-28	2002-11-30	2002-08-31	2002-05-31	2002-02-28	2001-11-30	2001-08-31
Cost Of Revenue	42,608	38,811	38,619	44,715	40,208	40,351	39,232	40,543	35,387	37,725	36,832	34,522	32,652	32,596	34,452	28,120	29,481	28,459	27,825	44,695	39,650	42,394	40,873	40,850	38,403	43,975	44,182	44,579	41,810	44,019	43,066	51,892	43,900	43,400	40,529	45,340	48,746	44,493	41,182	46,534	42,560	43,686	41,097	45,791	40,370	42,919	43,947	26,522	22,153	24,868	22,285	23,861	22,927	21,836	21,487	25,320	21,934	21,852	19,960	20,127	19,225	18,771	16,866	17,439	15,407	16,042	15,025	16,807	10,789	10,125	8,339	9,985	8,237	7,861	6,847	7,576	6,885	6,338	6,112	6,599	5,552	5,589	4,922	5,402	4,856	7,848	0	3,786	4,318	3,667	3,562
Depreciation And Amortization	7,522	6,685	6,688	7,557	7,838	7,818	7,485	7,667	7,406	7,279	6,997	6,524	6,379	6,436	6,577	6,255	6,440	5,903	5,207	6,722	6,867	6,692	5,599	5,768	5,718	5,884	5,793	6,356	6,169	6,133	6,153	6,980	6,979	7,197	7,223	7,716	8,777	7,314	7,266	6,140	6,549	6,263	6,097	6,653	6,810	6,292	9,314	3,583	3,188	3,141	3,132	3,467	3,128	2,142	3,029	3,271	3,037	2,451	3,079	3,182	3,091	2,877	2,905	2,507	2,315	2,135	1,912	1,870	1,031	383	125	326	263	268	225	208	189	191	183	152	-1	0	-	-10,070	0	-	-	0	-	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	-11,598	-302	-54,490	-2,555	-5,332	-3,662	-7,509	-4,339	-3,024	-5,827	-5,817	-4,200	-3,108	-3,626	-3,936	-8,215	-4,383	-1,695	126	55,332	5,680	7,033	4,874	7,698	9,019	5,691	6,328	17,881	8,884	-592	6,486	5,492	8,709	9,755	2,624	7,910	7,319	10,413	10,461	11,401	5,363	4,492	3,334	10,083	11,632	9,650	7,566	11,965	7,448	7,099	5,177	11,098	5,426	7,203	3,648	6,565	5,826	5,610	3,763	5,030	3,045	5,730	4,250	7,006	4,716	5,152	3,704	3,945	-20,108	2,962	1,664	3,091	2,851	2,326	1,875	2,497	2,432	1,793	1,270	1,916	1,069	0	0	1,048	0	0	0	0	0	0	0
Ebitda	-4,076	6,383	-47,802	5,002	2,506	4,156	-24	3,328	4,382	1,452	1,180	2,324	3,271	2,810	2,641	-1,960	2,057	4,208	5,333	62,054	12,547	13,725	10,473	13,466	14,737	11,575	12,121	24,237	15,053	5,541	12,639	12,472	15,688	16,952	9,847	15,626	16,096	17,727	17,727	17,541	11,912	10,755	9,431	16,736	18,442	15,942	16,880	15,548	10,636	10,240	8,309	14,565	8,554	9,345	6,677	9,836	8,863	8,061	6,842	8,212	6,136	8,607	7,155	9,513	7,031	7,287	5,616	5,815	-19,077	3,345	1,789	3,417	3,114	2,594	2,100	2,705	2,621	1,984	1,453	2,068	1,068	0	-	-9,022	6,800	-	-	0	-	-	-
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	72,486	5,405	5,727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	32,574	40,262	40,060	46,359	40,504	45,078	42,305	46,455	38,583	40,555	40,139	42,320	38,530	40,174	35,764	30,212	40,299	41,544	38,217	51,605	46,691	49,109	44,467	47,467	45,448	42,731	41,229	42,335	43,792	45,010	45,032	41,477	43,484	45,834	43,174	45,557	37,851	47,656	46,149	47,531	45,635	44,930	42,482	44,242	41,201	44,088	39,459	31,168	29,414	33,231	32,146	32,569	31,721	31,536	30,020	34,957	30,273	31,607	30,132	32,693	30,222	29,693	27,457	29,313	25,318	25,455	22,501	24,048	15,949	14,244	11,926	13,607	11,548	10,846	9,520	9,756	8,565	8,064	6,993	7,520	6,093	0	0	5,833	6,800	0	0	16,126	0	0	0
Income Before Tax	-202,489	-12,618	34,861	-21,865	-9,664	-9,051	-13,857	-6,721	-5,757	-8,863	-8,608	-21,939	-4,127	-5,173	-4,813	-155,909	-6,533	-3,302	-1,391	56,136	1,079	2,731	-477	3,327	4,071	83	-16	-10,028	4,557	14,415	2,903	-3,965	1,012	-728	-674	-267	-11,979	2,830	1,693	2,271	5,584	-86	-647	-801	-1,821	3,132	-1,154	-8,073	-2,880	3,569	2,103	-2,316	5,070	5,135	2,953	5,819	5,360	5,030	3,410	4,468	2,723	4,390	3,571	725	7,841	4,953	3,809	4,822	-19,039	4,053	2,992	3,325	3,113	2,605	2,079	2,615	1,903	1,815	1,285	1,795	862	950	687	795	579	534	346	550	443	572	5
Income Tax Expense	-12,050	16,430	-11,023	-398	-179	-565	-853	-455	-799	-512	-1,636	-2,471	-583	-905	-545	158	-824	-566	-116	-2,737	283	591	-8	1,225	-9,948	-166	19	885	1,670	681	1,603	39,997	382	-366	83	547	-7,717	1,492	1,064	3,349	476	13	-221	68	-829	1,163	-433	-1,045	-1,112	1,240	730	-1,564	1,259	1,856	1,065	2,080	2,027	1,901	1,299	1,566	811	1,483	1,360	206	2,951	1,853	1,429	1,896	-2,634	1,599	1,094	1,287	1,233	950	786	948	818	779	524	249	330	344	379	262	-163	308	236	203	96	230	32
Interest Expense	394	534	119	901	736	684	381	185	173	174	156	185	226	235	215	235	166	41	465	1,410	1,442	1,330	917	839	740	760	723	668	635	813	723	789	809	998	800	746	859	793	799	534	917	959	1,246	1,285	1,271	1,383	1,332	179	102	111	116	140	119	116	124	127	137	237	171	179	193	134	225	223	364	367	374	700	128	30	32	35	33	34	37	37	38	38	36	126	131	241	260	263	266	269	223	215	216	216	216
Interest Income	0	0	119	0	0	0	0	0	0	0	0	0	0	0	0	235	166	41	465	5,099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-190,439	-29,048	45,884	-21,467	-9,485	-8,486	-13,004	-6,266	-4,958	-8,351	-6,972	-19,468	-3,544	-4,268	-4,268	-156,067	-5,709	-2,736	-1,275	58,873	796	2,140	-469	2,102	14,019	249	-35	-10,913	2,887	13,734	1,300	-43,962	630	-362	-757	-814	-4,262	1,338	629	-1,078	5,108	-99	-426	-869	-992	1,969	-721	-7,028	-1,768	2,329	1,373	-752	3,811	3,279	1,888	3,739	3,333	3,129	2,111	2,902	1,912	2,907	2,211	519	4,890	3,100	2,380	2,926	-16,405	2,454	1,898	2,038	1,880	1,655	1,293	1,666	1,085	1,036	761	1,546	532	606	308	533	163	226	110	347	347	342	0
Net Income Applicable To Common Shares	0	0	45,884	45,884	-9,485	-8,486	-13,004	-6,266	-4,958	-8,351	-6,972	-19,468	-3,544	-4,268	-4,268	-157,067	-5,709	-2,736	-1,275	58,873	796	2,140	-469	2,102	14,019	249	-35	-12,913	2,887	13,734	1,300	-44,184	594	-362	-757	-814	-4,262	1,338	470	-1,917	5,108	-99	-426	-868	-992	1,969	-721	-7,028	-1,768	2,329	1,373	4,306	3,811	3,279	1,888	3,739	3,333	3,129	2,111	2,902	1,912	2,907	2,211	519	4,890	3,100	2,380	2,926	-2,455	2,455	1,898	2,038	1,880	1,655	1,293	1,666	1,085	1,036	761	1,546	683	606	308	533	317	226	110	347	347	342	0
Net Income From Continuing Ops	0	-29,048	45,884	-21,467	-9,485	-8,486	-13,004	-6,266	-4,958	-8,351	-6,972	-19,468	-3,544	-4,268	-4,268	-157,067	-5,709	-2,736	-1,275	-13,613	796	2,140	-469	2,102	14,019	249	-35	-12,913	2,887	13,734	1,300	-43,590	630	-362	-757	-814	-4,262	1,338	470	-1,917	5,108	-99	-426	-868	-992	1,969	-721	-7,028	-1,768	2,329	1,373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	0	534	119	-901	-736	-684	-381	-185	-173	-174	-156	-185	-226	-235	-215	-235	-166	-41	-465	-1,410	-1,442	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-	-
Non Operating Income Net Other	0	0	0	0	0	-252	-175	0	-289	-10	0	0	-163	-102	524	-970	-131	162	-98	-5,234	-266	80	114	-3,331	-49	-280	567	-2,053	52	-1,173	54	1,193	-1,675	-2,045	-1,744	-1,607	-1,828	-1,746	-1,824	-1,621	-1,985	-1,660	-1,934	-2,030	-1,879	-1,990	-1,838	-1,226	-123	-357	-614	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-	-
Non Recurring	0	0	0	0	0	3,059	5,581	0	2,359	2,253	0	0	610	1,128	1,319	148,575	1,565	1,421	1,500	-1,349	2,550	2,728	4,422	3,750	4,177	4,766	2,989	221	1,750	7,861	2,417	4,441	3,042	3,913	2,143	-5,341	18,779	2,302	2,664	1,255	3,016	2,679	2,002	7,332	5,787	2,264	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-11,598	-13,120	35,030	-2,555	-5,332	-3,662	-7,509	-4,339	-3,024	-8,679	-8,100	-21,587	-3,738	-4,836	-5,122	-155,611	-6,236	-3,423	-828	11,089	2,787	3,981	326	4,435	4,860	1,123	140	-9,333	5,140	15,588	3,572	-2,130	2,687	1,317	1,070	1,340	-10,151	4,575	3,577	3,749	7,569	1,574	1,287	1,231	58	5,122	684	-6,847	-2,757	3,926	2,717	-2,019	5,248	5,397	3,481	6,383	5,593	5,320	3,575	4,762	2,630	4,890	3,822	321	7,603	4,790	3,521	4,032	-20,084	3,004	1,823	3,104	2,889	2,399	1,914	2,517	2,148	1,793	1,270	1,916	1,069	1,187	943	1,048	6,800	1,355	0	756	651	776	205
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	86,780	85,784	88,409	93,502	86,044	88,839	89,046	91,198	76,705	84,097	82,436	80,875	74,127	76,294	74,676	66,484	74,032	71,860	65,818	87,425	80,395	84,550	80,580	80,350	74,783	80,735	82,177	82,640	78,590	81,531	81,666	91,688	81,686	83,698	80,135	86,272	88,013	84,655	80,312	86,490	81,764	83,423	79,557	84,376	75,726	79,621	80,200	55,744	49,283	52,765	50,791	52,039	49,400	47,203	48,026	53,894	46,614	48,139	46,517	48,058	46,817	43,574	40,501	46,431	33,122	36,707	34,005	36,823	46,822	21,365	18,442	20,488	16,896	16,308	14,453	14,815	13,302	12,609	11,835	12,203	10,577	0	0	20,257	0	0	0	0	0	0	0
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-	-
Reconciled Depreciation	0	6,685	6,688	7,557	7,838	7,818	7,660	7,667	7,406	7,279	6,997	6,524	6,379	6,436	6,577	6,255	6,440	5,903	5,207	6,722	6,867	6,692	5,599	5,768	5,718	5,884	5,793	6,356	6,169	6,133	6,153	6,716	6,979	7,197	7,223	7,716	8,777	7,299	6,700	6,140	6,549	6,263	6,097	6,653	6,810	6,292	9,314	3,595	3,188	3,141	3,132	3,519	3,128	2,955	3,029	3,271	3,037	3,140	3,079	3,182	3,091	2,877	2,905	2,507	2,315	2,135	1,912	1,870	1,031	383	125	326	263	268	225	208	189	191	183	152	0	0	-	0	0	-	-	0	-	-	-
Research Development	8,189	8,658	7,941	7,860	6,852	6,838	8,333	7,866	7,280	8,199	7,394	9,104	8,565	9,712	9,009	7,232	8,395	7,764	6,292	7,200	7,210	7,363	7,662	6,454	6,457	6,107	6,441	6,696	5,951	5,913	6,709	6,937	5,808	6,179	6,202	7,289	6,855	6,069	6,718	6,753	7,045	7,003	6,709	6,438	5,793	7,014	7,074	5,222	4,574	5,125	5,591	5,549	5,322	5,259	5,242	5,374	4,289	4,763	4,849	4,835	4,692	4,425	3,962	4,064	3,955	3,694	2,711	3,043	14,248	1,637	1,627	1,359	1,446	1,545	1,519	1,294	1,026	1,122	1,128	954	866	870	751	740	593	603	573	609	515	477	350
Selling And Marketing Expenses	25,405	25,464	27,368	26,293	25,406	26,007	26,543	26,833	20,416	23,606	24,446	23,820	19,607	20,174	17,705	18,207	20,934	20,113	19,380	21,843	19,413	20,269	19,433	20,898	18,009	18,967	19,402	20,476	19,469	19,524	19,488	21,191	20,301	20,569	20,559	20,218	19,355	20,981	20,067	21,464	20,700	21,073	19,963	20,387	18,520	18,671	18,543	16,546	15,802	15,847	16,308	15,333	14,553	13,793	14,444	16,490	14,032	15,042	15,359	16,050	13,651	13,993	13,091	0	11,725	11,267	10,549	0	8,048	6,689	5,730	6,378	5,294	5,202	4,524	4,618	4,147	3,773	3,463	0	0	0	-	0	0	-	-	0	-	-	-
Selling General Administrative	10,578	9,289	10,856	10,228	8,839	10,835	10,101	11,103	8,727	9,678	8,943	9,131	9,011	9,219	8,557	8,221	10,203	10,994	8,453	8,561	8,780	9,336	8,496	7,946	7,723	7,540	8,056	8,316	7,000	7,784	8,168	6,906	6,784	8,089	7,427	7,658	6,917	7,973	7,335	6,939	6,231	6,323	6,528	6,273	6,046	6,910	6,899	4,962	4,434	4,625	4,312	4,722	4,346	4,173	4,586	4,254	4,075	4,031	4,077	4,736	6,926	4,143	4,331	16,328	3,409	4,063	4,132	15,210	13,737	2,914	2,746	2,762	1,919	1,700	1,563	1,332	1,244	1,376	1,132	4,650	4,159	4,905	4,592	4,785	4,232	3,999	3,608	3,868	3,165	3,160	2,976
Tax Provision	0	16,430	-11,023	-398	-179	-565	-853	-455	-799	-512	-1,636	-2,471	-583	-905	-545	158	-824	-566	-116	-4,422	283	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	0	-	-	-
Total Operating Expenses	44,172	46,973	49,790	48,787	45,836	48,488	49,814	50,655	41,318	46,372	45,604	46,353	41,475	43,698	40,224	38,364	44,551	43,401	37,993	42,730	40,745	42,156	39,707	39,500	36,380	36,760	37,995	38,061	36,780	37,512	38,600	39,796	37,786	40,298	39,606	40,932	39,267	40,162	39,130	39,956	39,204	39,737	38,460	38,585	35,356	36,702	36,253	29,222	27,130	27,897	28,506	28,178	26,473	25,367	26,539	28,574	24,680	26,287	26,557	27,931	27,592	24,803	23,635	28,992	17,715	20,665	18,980	20,016	36,033	11,240	10,103	10,503	8,659	8,447	7,606	7,239	6,417	6,271	5,723	5,604	5,025	0	0	14,855	0	0	0	0	0	0	0
Total Other Income Expense Net	-190,891	-6,441	44,472	-19,310	-4,332	-5,389	-6,348	-2,382	-2,733	-2,872	-2,987	-17,721	-956	-1,414	-138	-147,522	-2,115	-1,404	-1,150	48,671	-3,425	-2,892	-4,320	-3,801	-4,257	-5,128	-3,250	-14,302	-2,455	6,917	-2,810	-5,646	-4,686	-6,264	-3,443	-4,892	-10,563	-4,664	-5,326	-5,304	70	-4,320	-3,423	-6,458	-7,666	-4,254	-4,360	-10,019	-5,164	-1,765	-1,537	-6,707	-178	-1,034	-571	-619	-233	-290	-182	-383	-129	-840	-428	-6,685	2,887	-362	-183	87	24	42	159	13	38	73	39	20	-284	22	15	-121	-207	0	0	-253	0	0	0	0	0	0	0
Total Revenue	75,182	79,073	78,679	91,074	80,712	85,429	81,537	86,998	73,970	78,280	76,971	76,842	71,182	72,770	70,216	58,332	69,780	70,003	66,042	96,300	86,341	91,503	85,340	88,317	83,851	86,706	85,411	86,914	85,602	89,029	88,098	93,369	87,384	89,234	83,703	90,897	86,597	92,149	87,331	94,065	88,195	88,616	83,579	90,033	81,571	87,007	83,406	57,690	51,567	58,099	54,431	56,430	54,648	53,372	51,507	60,277	52,207	53,459	50,092	52,820	49,447	48,464	44,323	46,752	40,725	41,497	37,526	40,855	26,738	24,369	20,265	23,592	19,785	18,707	16,367	17,332	15,450	14,402	13,105	14,119	11,645	11,851	10,630	11,235	6,800	8,768	8,328	8,410	8,134	7,603	6,743

Latest Income Statement (annual, 2023-05-31)

Gross Profit (+$)
totalRevenue	338,752
Cost of Revenue	-164,506
Gross Profit	174,246	174,246

Operating Income (+$)
Gross Profit	174,246
Operating Expense	-192,925
Operating Income	-19,233	-18,679

Operating Expense (+$)
Research Development	29,883
Selling General Administrative	40,003
Selling And Marketing Expenses	104,249
Operating Expense	192,925	174,135

Net Interest Income (+$)
Interest Income	0
Interest Expense	-2,702
Other Finance Cost	-0
Net Interest Income	-2,702

Pretax Income (+$)
Operating Income	-19,233
Net Interest Income	-2,702
Other Non-Operating Income Expenses	-554
Income Before Tax (EBT)	-54,437	15,971 EBIT - interestExpense = -21,935 -54,437 -49,740
Interest Expense	2,702
Earnings Before Interest and Taxes (EBIT)	-19,233	-51,735
Earnings Before Interest and Taxes (EBITDA)	11,640

After tax Income (+$)
Income Before Tax	-54,437
Tax Provision	--1,995
Net Income From Continuing Ops	-52,442	-52,442
Net Income	-52,442
Net Income Applicable To Common Shares	-52,442

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	32,502
Other Operating Expenses	357,431
Total Other Income/Expenses Net	-35,204	3,256

Technical Analysis of Angiodynamics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Angiodynamics. The general trend of Angiodynamics is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Angiodynamics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-42.9%)		Bearish trend (42.9%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of AngioDynamics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.52 < 8.16 < 8.25.

The bearish price targets are: 6.325 > 6.325 > 6.28.

Tweet this

AngioDynamics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AngioDynamics Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

MA 20 trending up: The MA 20 is trending up. +1
Close < MA 20: The price is below the MA 20. -1
MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending up: The MA 50 is trending up. +1
Close > MA 50: The price is above the MA 50. +1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
MA 100 trending down: The MA 100 is trending down. -1
Close < MA 100: The price is below the MA 100. -1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

AngioDynamics Inc Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AngioDynamics Inc. The current macd is 0.17462166.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Angiodynamics price going down in the near term. -2
MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Angiodynamics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Angiodynamics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

AngioDynamics Inc Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of AngioDynamics Inc. The current adx is 26.27.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Angiodynamics shares, leading to potential upward momentum in its price. +1
PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2

AngioDynamics Inc Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AngioDynamics Inc. The current sar is 7.30459898.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1

AngioDynamics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AngioDynamics Inc. The current rsi is 48.98. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Trending down: The RSI is trending down. -1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

AngioDynamics Inc Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AngioDynamics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Angiodynamics price going down in the near term. -2
Trending down: The STOCH %K is trending down. -1

AngioDynamics Inc Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AngioDynamics Inc. The current cci is -3.67580483.

AngioDynamics Inc Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AngioDynamics Inc. The current cmo is -9.70285482.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

AngioDynamics Inc Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of AngioDynamics Inc. The current willr is -79.54545455.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Angiodynamics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

AngioDynamics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of AngioDynamics Inc.

AngioDynamics Inc Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AngioDynamics Inc. The current atr is 0.361474.

AngioDynamics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AngioDynamics Inc. The current obv is -31,999,061.

AngioDynamics Inc Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AngioDynamics Inc. The current mfi is 60.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

MFI > 50: +1

AngioDynamics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for AngioDynamics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-27	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-11-29	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2023-12-01	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-05	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2023-12-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2023-12-07	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-08	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-13	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-22	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-28	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2023-12-29	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-01-03	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-01-05	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-10	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-22	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
2024-01-29	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-01-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-02	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-05	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-02-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-08	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-09	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-02-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-15	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-16	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-21	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-02-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-23	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-02-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-28	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-29	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-03-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-06	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-08	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-03-11	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-03-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-15	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-03-18	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-19	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-03-21	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-22	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-25	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-03-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-27	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-28	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-02	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-03	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-04	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2024-04-08	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-09	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-04-10	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2024-04-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-12	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-16	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-17	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-18	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside

6.3. Candlestick Patterns

AngioDynamics Inc Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of AngioDynamics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	48.983
Ma 20	Greater than	Ma 50	6.176
Ma 50	Greater than	Ma 100	5.935
Ma 100	Greater than	Ma 200	6.340
Open	Greater than	Close	6.350
Total			2/5 (40.0%)

Create your own Symbol Scanner

Get notifications about AngioDynamics Inc

I send you an email if I find something interesting about AngioDynamics Inc.

AngioDynamics Inc Buy, Hold or Sell?

Let's analyse Angiodynamics together

Get notifications about AngioDynamics Inc

Quick analysis of Angiodynamics (30 sec.)

What can you expect buying and holding a share of Angiodynamics? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Angiodynamics (5 min.)

$6.12

$5.37

$-23.45 - $-1.82

$-18.08 - $3.54

2. Growth of Angiodynamics (5 min.)

Is Angiodynamics growing?

How much money is Angiodynamics making?

How much money comes from the company's main activities?

3. Financial Health of Angiodynamics (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

What can you expect buying and holding a share of Angiodynamics? (5 min.)

What can you expect buying and holding a share of Angiodynamics?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Angiodynamics

About AngioDynamics Inc

Financial Health

Valuation

1.1. Profitability of AngioDynamics Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Instruments & Supplies)

1.2. Operating Efficiency of AngioDynamics Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3. Liquidity of AngioDynamics Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4. Solvency of AngioDynamics Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

2. Market Valuation of AngioDynamics Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

AngioDynamics Inc
Buy, Hold or Sell?